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Abstract 
There has been a growing interest in human microbiome studies in the past decade, with 
the development of high-throughput sequencing techniques. These microorganisms 
interact and respond to the host as an entity, and are involved in various homeostatic 
functions including nutrition digestion, immune response, metabolism and endocrine 
regulation. The urinary microbiome, however, remains relatively under-investigated. 
One of the technical challenges of urinary microbiome studies is the samples usually 
contain a large number of host cells and low microbial biomass. These samples with the 
high host, low microbial abundance (“high-low” samples) are associated with increased 
risk of compromised quality of 16s rRNA gene sequencing results. An analysis with 
mock samples showed that mechanisms of host materials interfering with microbiome 
analysis includes reducing microbial DNA extract yield by competitively binding to the 
filter of DNA extraction column, inhibiting PCR amplification of 16S rRNA gene regions 
as non-target DNA, and consuming sequencing depth by unspecific amplification from 
PCR. To counter these issues, a refined processing protocol and a quality checking tool 
were developed for handling “high-low” samples. With these methods, a combination of 
sequencing-based methods and enhanced culture-based methods showed evidence of 
bacteria in renal tissue samples. 
On the other hand, the optimal urine sample collection and storage methods for 
microbiome study have not been reported. An optimisation experiment showed that urine 
samples with a volume higher than 20 mL and stored in centrifuged pellets generated the 
best sequencing results.  
The urinary microbiome of healthy subjects and urinary stone patients were characterised 
using 16s rRNA gene sequencing and enhanced quantitative urine culture (EQUC) 
techniques. Although no clear distinction was observed of urinary microbiome profiles 
between healthy subjects and urinary stone patients, male and female individuals do have 
their unique urinary microbiome profiles. The urinary microbiome profile of an 
individual remained stable throughout three months.  
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Investigation of urine samples of metabolic stone patients before and after lithotripsy 
showed fluctuations in their urinary microbiome profiles, with newly-emerged microbes 
in sequencing results correlated with microbes cultured from stone samples. These results 
suggested bacteria liberated from metabolic stones during lithotripsy. 
 
Keywords 
Urinary microbiome, Urinary microbiota, 16s rRNA gene sequencing, enhanced 
quantitative urine culture, contamination, metagenomics, renal cell carcinoma, urinary 
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Chapter 1  
1 General Introduction  
This chapter has been adapted with permission from:   
• Di Bella, J. M., Bao, Y., Gloor, G. B., Burton, J. P., & Reid, G. (2013). High throughput sequencing 
methods and analysis for microbiome research. Journal of microbiological methods, 95(3), 401-414. 
• Bao, Y., Welk, B., Reid, G., & Burton, J. P. (2014). Role of the microbiome in recurrent urinary 
tract infection. Novel Insights into Urinary Tract Infections and their Management, 49. 
• Bao, Y., Al, K. F., Chanyi, R. M., Whiteside, S., Dewar, M., Razvi, H., ... & Burton, J. P. (2017). 
Questions and challenges associated with studying the microbiome of the urinary tract. Annals of 
translational medicine, 5(2). 
1.1 The human microbiome 
The human microbiome is usually defined as all microbial populations (bacteria, fungi, 
archaea, and viruses) together with their genes and genomes that inhabit the human body 
(Turnbaugh et al., 2007). Another related term is “microbiota”, which refers to only the 
bacteria present at a particular site. Lots of these microbes are commensal, and their 
mutualistic relationship with the host has been reported. This relationship is more 
apparent upon study of the gut microbiome, which contains the highest abundance of 
microbes associated with any site in/on the human body.  Within the gut, microorganisms 
uptake nutrients primarily from ingested food, and fulfill a number of homeostatic 
functions including the maintenance of barrier function, immune regulation, defence 
against pathogens (Round & Mazmanian, 2009) and digestion of complex substances 
from the human diet that are otherwise difficult to break down (Gill et al., 2006). Many 
of these microorganisms may be potential pathogens, but it is believed that these 
microbes are controlled and limited by the whole microbial ecosystem in the niche. The 
components and structure of such microbial ecosystems may change over time, but in 
most occasions, for a healthy subject, such a community maintains its relative stability 
(Ley et al., 2006). Disruption of this stability could cause, or be the result of, a 
“dysbiotic” state which usually links to pathological conditions including inflammatory 
bowel disease (Garrett et al., 2010), dental caries (Ling et al., 2010), and obesity (Ley et 
al., 2006). 
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1.2 High throughput, culture-independent sequencing 
methods for microbiome study 
 Our current understanding of the human microbiome has largely been due to the recent 
advancements in sequencing technologies allowing for high-throughput assessment of 
microbiome populations at relatively low cost. These studies have shown different body 
sites have distinct microbiological communities, and these communities differ between 
individuals (Turnbaugh et al., 2007). 
Despite the fact that microbial cells vastly outnumber eukaryotic cells in the human body, 
most of the microbes have not yet been cultivated (Amann et al., 1995). Therefore, most 
uncultivated microorganisms remain to be fully characterized. With the recognition that 
DNA sequences, particularly the 16S ribosomal gene sequence, are useful phylogenetic 
markers and microbial identifiers, scientists are starting to gain an appreciation of the 
complexity of microbial ecosystems (Pace et al., 1997 & 2009; Woese et al., 1987). 
These developments, along with those of PCR and in situ hybridization, have led to a 
shift toward culture-independent studies of microbial communities. 
1.2.1 Common strategies of sequencing-based methods for 
microbiome study 
 Three commonly used sequencing-based methods for investigating the microbiome are 
amplicon, metagenome, and meta-transcriptome. In amplicon sequencing, a certain gene 
or gene fragment is amplified, and the sequence is determined. This sequence is then used 
as a comparator to other similar sequences within other microorganisms.  If a highly 
conserved genetic locus is chosen, such as segments of the 16S rRNA gene, the 
organisms are able to be taxonomically identified.  By comparing the organisms present 
within multiple samples, researchers can identify how each differs within the 
environment.  
While amplicon-style analysis only depends on a single gene, to obtain more detailed 
information regarding the particular sample, a metagenomic approach is used. Here, the 
aim is to determine the total genetic composition of all microorganisms present in order 
to make inferences about the functionalities or pathways present in these bacteria.  With 
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sufficient sequencing depth, metagenomic sequencing captures higher resolution 
differentiating closely related organisms than 16s rRNA gene sequencing and is less 
susceptible to PCR-associated bias (Poretsky et al., 2014). This technique can also be 
utilized to explore the physiological capability of certain microbes in a sample with its 
ability to obtain information of certain functional gene pathways. The main limitation of 
metagenomic sequencing includes high cost and its dependence on gene library. 
 The previous two methods allow for the identification of the bacteria present in a sample, 
or their genetic potential.  However, these methods do not identify what these microbes 
are functionally producing.  For this, meta-transcriptome sequencing (RNA-Seq) is used. 
All mRNA transcripts in a sample are sequenced and then analyzed to determine relative 
or differential gene expression between different conditions or samples. All approaches 
rely on a high-throughput sequencing technology, but differ in their sample preparation, 
sequencing approach and bioinformatic analyses. 
Studies of the microbiome require high-quality data to generate accurate results. 
Therefore, each step of the processing streamline requires rigorous quality control, 
including optimal sample collection methods, a sufficient number of samples, obtaining 
samples from biologically relevant sites, controlling for confounding factors, choosing 
appropriate sequencing platforms and using appropriate analytical tools. Each of these 
factors will be discussed in later sections. 
1.2.1.1 Sample collection and metadata acquisition.  
Optimal methods for sample collection and storage vary for different sample types. For 
microbe-rich samples such as stool, different collection and storage conditions yield 
reproducible sequencing results (Al et al., manuscript under review). However, for 
samples with low microbial biomass or samples in liquid or gaseous form, care should be 
taken during processing to avoid compromising quality. Sequencing results of samples 
with low microbial biomass are easily confounded by environmental or reagent 
contamination (Salter et al., 2014), and in certain cases it is almost impossible to retrieve 
an accurate profiling of the microbial community in the target niche (Kennedy et al. 
2014; D. Kim et al., 2017; Salter et al., 2014). Liquid samples may require optimization 
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for reliable storage. For example, when storing urine it is best to avoid cycles of freezing 
and thawing as this process damages the cellular structure of microbes, and the DNA is 
lost in the liquid phase of the sample. In such cases, concentrating the bacterial 
component of the sample and storing in pellet form may be required.  
Acquisition and recording of metadata is another very important factor. Metadata is any 
information regarding the samples.  The metadata can include but is not limited to where 
the sample came from, when it was collected, how it was collected, the estimated 
microbial abundance, risk of contamination of that environment, how that sample was 
processed and sequenced. The metadata that should be collected depends on the nature of 
the sample.  With regards to a soil sample, it would be useful to record the latitude, 
longitude, and depth where sampling occurred.  Whereas for a human oral swab it would 
be useful to record age, gender and all aspects of the health and/or disease status. 
Metadata recording is becoming increasingly important as more metagenomic and meta-
transcriptomic sequences are submitted to databases; it is helpful to be able to search by a 
disease state, habitat or other characteristics. It is also useful to have information stored 
about the methods used to obtain the sequences, such as the sequencing platform used. 
The Genome Standards Consortium has proposed checklists for metadata such as the 
Minimum Information about any Sequence (MIxS), the Minimum Information about a 
Marker Sequence (MIMARKS), and the Minimum Information about a Metagenome 
Sequence (MIMS) checklists in order to standardize the metadata collected, as well as 
“environmental packages” for specific sample types (Yilmaz et al., 2011). Beyond 
submission to databases, metadata are also useful for any study in which samples are 
being compared—the more metadata that are available, the more information a researcher 
has about how the samples differ and how these might affect microbiome findings.   
1.2.1.2 Nucleic acid extraction and library preparation 
Microbial genomic DNA extraction and purification serve as the first step of library 
preparation. Since most sequencing protocols require nanogram to microgram quantities 
of DNA, efficient DNA isolation and purification is critical to ensure proper 
representation of the microbial community present. Cell lysis and subsequent DNA 
extraction from certain microbes, especially those living in extreme environments, can be 
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difficult as these organisms have rigid cell wall structures and may also release stable 
nucleases upon lysis. However, since such microbes are an interesting source for 
bioprospecting new enzymes and other components, efforts are constantly made to 
perform those challenging DNA extractions. With the application of mechanical lysis 
(bead beating and sonicating), chemical lysis (Sodium dodecyl sulfate (SDS), phenol) 
and enzymatic lysis (proteinase K, mutanolysin, etc.), high-quality DNA has been 
retrieved from a variety of environments including soil (Hårdeman & Sjӧling, 2006; 
Pathak et al., 2009; Voget et al., 2006; Waschkowitz et al., 2009), marine picoplankton 
(Stein et al., 1996), saline soil (Purohit et al., 2009), contaminated subsurface sediments 
(Abulencia et al., 2006), groundwater (Uchiyama et al., 2005), hotsprings, mud holes in 
solfataric fields (Rhee et al., 2005) and many other locations. To avoid wasting expensive 
reagents for library preparation and sequencing, the quantity and quality of the DNA need 
to be confirmed before amplification and sequencing. Many different technologies exist 
for measuring quality, such as the 2100 Bioanalyzer (Agilent Technologies), fluorimeters 
(Qubit, Life Technologies), spectrometers (Nanodrop) and quantitative PCR for DNA 
damage identification (Ginzinger et al., 2000). After verification of quality and quantity, 
the DNA templates can go through further preparation steps. 
1.2.1.3 High throughput sequencing methodologies 
 The first-generation DNA sequencing technology was developed by Sanger et al.(Sanger 
et al., 1977) based on the selective incorporation of chain-terminating dideoxynucleotides 
and required manual determination of the sequence. The first automatic sequencing 
machine (AB370) was produced by Applied Biosystems in 1987 (L. Liu et al., 2012). 
Using the Sanger technique, the first bacterial genome sequence was completed in 1995 
(Fleischmann et al., 1995), and constituted the main part of the Human Genome Project 
in 2001(Collins et al., 2003).  These technical advancements promoted further 
development of sequencing technology. With the launch of the Genome Sequencer 20 
system by 454 Life Sciences in 2005, second-generation sequencing techniques came into 
recognition with massively parallel analysis, high-throughput and reduced cost. This 
significant advance reduced the difficulty of sequencing (Metzker et al., 2005) and made 
it possible to analyze bacterial genomes in days rather than months or years (Loman et 
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al., 2012). While most second-generation sequencing techniques rely on a sequencing-
by-synthesis design, the newly emerged third-generation sequencing techniques are 
performed on a single-molecule basis with no initial DNA amplification step. The 
features of each next-generation sequencing device are summarized in Table 1.1. 
1.2.1.4 General considerations for high throughput sequencing 
One of the first questions a scientist considering using high-throughput sequencing 
should ask is: Is this methodology required to answer the scientific question? While the 
sequencing is increasing in popularity, speed, reliability and decreasing in cost, it is not 
always the appropriate tool to be used.  For some experiments, other methods such as 
microarrays may be appropriate and yield results that are more appropriate for the 
specific hypotheses being addressed. However, because of its the depth and relatively 
unbiased nature, the high-throughput sequencing technique is, in many cases, replacing 
microarray technologies. 
If sequencing is the appropriate tool, the second question is which platform should be 
used.  There are many different platforms on the market each with their distinct strengths 
and weaknesses. Some may generate the largest total throughput per run, while others 
may have better speed, read length or accuracy. The appropriate selection depends on the 
aims of the experiment. In some cases, a combination of techniques could provide higher 
coverage of the genome. 
To increase the efficiency of sequencing, microbial samples are usually barcoded and 
multiplexed. Understanding the complexity of your samples is critical to determine 
whether multiplexing is needed and how many samples can be assayed in a single run. If 
using a multiplexing approach, the concentration of each sample should be similar so that 
equal amounts of data are achieved for each multiplexed sample. 
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Table 1 Comparison of next-generation sequencing techniques 
 
 
  
Sequencing Device Chemistry Read Length (bp) Run Time Throughput per run Reads per run 
High-end instruments      
454 GS FLX + (Roche) Pyrosequencing 700 23h 700 Mb 
~1,000,000 shotgun, 
~700,000 amplicon 
HiSeq 2000/2500 
(illumine) 
Reversible 
terminator 
2 x 150 
High output: ~11 days 
Rapid run: ~27h 
High output: 600 Gb 
Rapid run: 120 Gb 
High output: 3 billion x 2 
Rapid run: 600 million x 2 
5500xl W SOLiD (Life 
Technologies) 
Ligation 1x75 Frag, 2x50 MP 8 days ~320 Gb 1.4 billion x2 
Bench-top devices      
454 GS Junior (Roche) Pyrosequencing 400 8h 35 Mb 
100,000 shotgun 
70,000 amplicon 
Ion PGM (Life 
Technologies) 
Proteon 
detection 
100 or 200 3h 
100 Mb (314 chip) 
1 Gb (316 chip) 
2 Gb (318 chip) 
400-550 thousand (314 chip) 
2-3 million (316 chip) 
4-5.5 million (318 chip) 
MiSeq (Illumina) 
Reversible 
terminator 
2x250 27h 8.35 Gb 
6.8 million (LRGC routinely 
getting > 15M) 
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1.2.2 Common applications of high-throughput sequencing and 
bioinformatic tools 
High-throughput sequencing techniques produce massive amounts of data.  To determine 
if and what conclusions can be made, it is necessary to analyze the information 
computationally. In this section, the most commonly used methods and tools for targeted 
amplicon sequencing analysis, shotgun metagenome analysis, and meta-transcriptome 
analysis will be discussed, as well as what technologies are emerging. Figure 1 details a 
summary of the steps for bioinformatic analyses for each of the different methodologies. 
Amplicon sequencing will be the major focus going forward as this technology is the 
primary one used for this thesis. 
1.2.2.1 Targeted amplicon sequencing and analysis of bacterial 
diversity 
Amplifying and sequencing variable regions of highly conserved bacterial genes is a 
common way to determine the taxonomic composition of a microbiome. By comparing 
them to existing databases, one can determine from which organisms the sequences are 
homologous to in order to make an inference into their identity, and thus determine the 
bacterial profiles and proportions within a sample. 
1.2.2.1.1 Amplicon choice 
Typically, the gene encoding the 16S rRNA subunit is used to analyze prokaryotic 
taxonomic composition in samples, as it is highly conserved in all prokaryotes. However, 
since the 16S rRNA gene is approximately 1550 base pairs in length, it is difficult to 
sequence the entirety of the gene using high-throughput sequencing methods without 
requiring an assembly step. While techniques such as expectation maximization iterative 
reconstruction of genes from the environment (EMIRGE) have been developed to 
assemble the full 16S gene for taxonomic studies (Miller, Baker, Thomas, Singer, & 
Banfield, 2011), it is not frequently used.  Increasing the length of the sequence decreases 
the depth of coverage, making it more difficult to assemble the gene and resolve rare 
taxa. 
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Figure 1 Flowchart detailing the steps in the bioinformatic analysis of sequence 
data. Boxes in red represent steps for amplicon sequence analysis, boxes in yellow 
represent steps for metagenome analysis, and boxes in blue represent steps for 
meta-transcriptome analysis 
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Instead, one or more of the nine variable (V) regions of the 16S rRNA gene are amplified 
and sequenced. However, the variable regions differ between species in different ways—
some species can be distinguished in one variable region but not the other. Schloss et al. 
reported that the use of different variable regions influences the way OTUs cluster and 
the reported richness and evenness of communities.  It was recommended to use caution 
in the analysis of these data and that the data should not be analyzed in the same way that 
one would analyze a full-length 16S rRNA gene sequence (Schloss et al., 2011). Kim et 
al. reviewed and analyzed commonly used primers to determine how the use of different 
variable regions for analysis affects OTU clustering, annotation, and estimates of 
diversity when applied to sequences available from the Ribosomal Database Project 
(RDP) database.  It was concluded that it is easiest to analyze the V1–V3 or V1–V4 
regions, as these are more variable and are better represented in the RDP database (Kim 
et al., 2011). Liu et al. also compared several designs of 16S rRNA gene amplicon 
sequencing and found that sequencing the V2–V3 regions produced the most accurate 
results, as determined by modeling short read sequence data based on full 16S rRNA 
gene sequences (Z. Liu et al., 2008).  It was also suggested that several primers in 
combination could be used (Z. Liu et al., 2008). Youssef et al. compared the effects of 
the choice in the variable region on the amount of OTUs detected and found that V4, V5–
V6, and V6–V7 sequencing produces the best estimates for species richness in a sample 
(Youssef et al., 2009). The Earth Microbiome Project (Gilbert et al., 2010) is 
standardized to amplify the V4 region since the primers for that region are 
complimentary homologous to most bacteria and archaea (www.earthmicrobiome.org).  
Similar to the sequencing platform used, the choice of which variable region to amplify 
depends on a variety of factors specific to the sample and experiment.  This includes the 
bacterial types likely present, level of taxonomic resolution (species, genus, or higher 
taxonomic level), and the read length that is afforded by the sequencer. Further studies 
relating to the effects of study design on the results of amplicon sequencing studies can 
be found in the several publications (Mizrahi-Man et al., 2013; Shah et al., 2011; Soergel 
et al. 2012). 
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While the 16S rRNA gene is by far the most frequently used gene for studies of 
community membership and structures, its use has limitations. One main criticism of the 
technique is that many bacteria have more than one copy of the rrn operon, which 
contains the 16S rRNA gene (Acinas et al., 2004). This is problematic for abundance 
studies based on these sequences since bacteria with more 16S rRNA copies will be over-
represented in a sample. Also, there can be high levels of sequence divergence between 
the multiple copies of the 16S rRNA gene present within the genome of a single 
bacterium, in particular when examining extremophiles (Acinas et al., 2004). These 
divergent sequences inflate the diversity estimates as their different rRNA genes make it 
appear that multiple bacterial variants are present when in reality it is a single bacterium. 
Lastly, many of the 16S rRNA gene primers are considered “universal” for all eubacterial 
sequences despite the fact they may preferentially bind to sequences from some taxa over 
others.  This will also over-represent some taxa while under-representing others. 
To combat these problems, other highly conserved genes have been used as an alternative 
to the 16S rRNA gene. The most commonly used alternative is cpn60 that encodes the 
type I chaperonin proteins. Previous research has shown that cpn60 sequencing has a 
better resolution to distinguish species compared to the16S rRNA gene (Hill et al., 2010; 
Schellenberg et al., 2009). However, in organisms with multiple copies of cpn60, they 
tend to be even more divergent than 16S rRNA genes and can potentially inflate 
taxonomic differences similarly to the case for multiple rRNA genes (Links et al., 2012). 
For other highly conserved genes, such as rpoB, no universal primers exist making these 
genes difficult to work with for studying the whole microbiome without bias. Another 
major disadvantage of using alternatives to the 16S rRNA gene is that databases for these 
genes are less well developed and thus annotation of the reads is more challenging (see 
Section 1.2.2.1.5 for details on annotation). 
1.2.2.1.2 Commonly used software packages and pipelines 
 Amplicon sequencing-based studies are becoming increasingly popular, and so a variety 
of pipelines and tools have been developed to facilitate analyses. Most of the tools 
described below can be found in these packages, allowing analysis of sequence data 
without having to learn many different programs. The most popular pipelines are 
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Quantitative Insights Into Microbial Ecology (QIIME)(Caporaso et al., 2010) and mothur 
(Schloss et al., 2009).  Each has the most common tools for analyses of amplicon 
sequencing data. 
For less common tools, the code is often available separately. One useful tool widely 
used is the software environment known as R. This is an open source programming 
language that is often used for statistical analyses and visualization of data (www.R-
project.org). Many software packages that are useful for analysis of microbiome data 
have been developed for use in R, such as vegan, used for assessing diversity 
(http://cran.r-project.org.proxy1.lib.uwo.ca/package=vegan), and phyloseq, used to 
analyze operational taxonomic unit abundance data (McMurdie & Holmes, 2013). 
1.2.2.1.3 Pre-processing of raw amplicon reads 
All sequencing methods have some error. Amplicon sequencing analysis is particularly 
vulnerable to erroneous conclusions caused by incorrectly sequenced reads, as errors in 
raw sequence reads can lead to erroneously high estimates of bacterial diversity (Kunin et 
al., 2010). Clustering reads based on sequence similarity counteracts some but not all of 
these effects (Kunin et al., 2010). Because of this, pre-processing is often used before 
further analysis. 
Quality-based pre-processing methods are commonly used to filter out low-quality reads, 
reducing the number of erroneous reads. Previous studies have filtered out reads with 
ambiguous bases, mismatches to primers, low-quality scores, or minimal or no sequence 
match to the amplified sequence (Huse et al., 2010). Another method that has been used 
is to use quality scores to trim lengths of low-quality sequence from the reads (Kunin et 
al., 2010), or trimming a fixed number of bases from the ends of reads.  This is used 
because sequence quality decreases with length and therefore this removes the lowest 
quality data from each read. 
For pyrosequencing methods such as Roche 454, additional tools exist to remove errors 
due to these techniques' tendency to have insertions and/or deletions in their sequences at 
homopolymeric tracts. Tools such as AmpliconNoise (Quince et al., 2011) and Denoiser 
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(Reeder & Knight, 2010) analyze the flowgrams from the sequencers to detect potentially 
erroneous reads. 
Another source of sequence artifacts is chimeric sequences created during the PCR 
amplification step. These forms when an aborted PCR product from one sequence binds 
to and acts as the primer for the extension of another sequence, thus creating a hybrid 
DNA molecule that was made from two templates (Hess et al., 2011). Like errors 
introduced by sequencing, chimeric sequences can be falsely interpreted as novel 
amplicons and thus incorrectly increase estimates of bacterial diversity (Huse et al., 
2010). Although the risk of chimeras forming is lower when sequencing variable regions, 
it is still worthwhile to check for them. A number of tools exist to detect and remove 
chimeric reads, including ChimeraSlayer that uses a reference set of amplicons (Hess et 
al., 2011), Perseus, that acts de novo (Quince et al., 2011), and UCHIME, that can either 
use a reference database or act de novo to detect chimeras (Edgar et al., 2011). 
1.2.2.1.4 Operational taxonomic unit (OTU) clustering 
 It is incorrect to assume that each unique read represents a different species: mutations 
and sequencing errors can lead to slightly different amplicon sequences within a species. 
To prevent this from interfering, reads are aligned, and those that are similar are clustered 
together forming operational taxonomic units (OTUs). The OTUs are defined by 
clustering together sequences that are below a particular percentage of divergence from 
each other. As this percentage increases, the number of reads clustered together increases, 
as the percentage decreases the number of OTUs must also decrease. Clustering of 
sequences in an OTU is a compromise between detecting more species than are actually 
present (interpreting mutations and sequence errors as separate species), and detecting 
fewer species than are actually present (clustering similar reads from different species 
into separate OTUs). Generally, a 97% identity thresh-hold is used as an approximation 
of species-level resolution.  Meaning, all reads in a single OTU do not have greater than 
3% sequence difference from each other (Stackebrandt & Goebel, 1994). 
Since determining which OTU a sequence belongs to requires comparison of all input 
sequences with each other, this procedure can take a large amount of computational 
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power, and thus, a lot of time to complete. To make this task easier, pre-clustering is 
performed. This involves collapsing all identical reads into one category; however, it is 
important that the abundance information for these reads is stored for use in subsequent 
quantitative analyses. Once the reads are pre-clustered, existing tools can be used to 
determine OTUs. 
There are two main independent approaches when assigning OTUs. The most commonly 
used is de novo OTU picking, this technique compares all sequences to each other and 
clusters them by similarity with no reference to outside sources of data. Cd-hit (W. Li & 
Godzik, 2006), UCLUST(Edgar et al., 2010), ESPRIT-Tree (Cai & Sun, 2011), CROP 
(Hao et al., 2011), BeBAC(Cheng et al., 2012), and M-pick (Wang et al. 2013) are all 
tools that can choose OTUs independent of taxonomy. The other approach to OTU 
picking is taxonomy-based where tools such as BLAST(Altschul et al., 1997) compare 
sequences to a database and cluster OTUs based on their sequence similarity to known 
sequences in the database. This approach is less likely to include erroneous sequences in 
the analysis and immediately annotates the clustered reads; however, it discards reads 
with sequences that do not match those in the database.  This eliminates potentially novel 
species. A third option is to combine the two approaches by using taxonomy-based OTU 
picking first, and then using de novo clustering on the remaining reads (Bik et al., 2012). 
1.2.2.1.5 Annotation  
Once OTUs are determined, it is necessary to find out from what species they came. The 
database used is dependent on the sequence amplified. For 16S rRNA gene sequences 
several databases exist. The SILVA database has sequences for both the small and large 
ribosomal subunits in prokaryotes as well as eukaryotes. Taxonomic classification of 
rRNA sequences can be done using the SINA tool, available on its website(Pruesse et al., 
2007). The Ribosomal Database Project (RDP) contains prokaryotic 16S rRNA 
sequences and has an RDP Classifier tool for taxonomic classification of rRNA gene 
sequences, as well as several other tools for 16S rRNA amplicon processing and 
analysis(Cole et al., 2008). GreenGenes also contains prokaryotic 16S rRNA sequences 
along with a tool to compare sequences to the database (DeSantis et al., 2006). There are 
fewer databases dedicated to other prokaryotic marker genes. For cpn60 sequences, the 
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cpnDB exists to aid annotation (Hill et al., 2004). For other markers, there are few or no 
dedicated databases.  In these cases, it is thought to be best to search against a general 
purpose protein database.  
1.2.2.1.6 Describing richness and evenness within samples 
Richness is a description of the number of species present in a sample, while diversity is 
a measure that combines richness with how evenly different species make up the sample's 
microbiome. Richness may be determined by the number of OTUs present, but this can 
be influenced by the sequencing depth, so metrics such as Chao1(Chao et al., 1984) and 
ACE (Chao & Lee, 1992) are used to estimate the minimum number of species present in 
the sample. Typically, the diversity within a sample is referred to as alpha-diversity. It is 
measured using the Simpson diversity index and the Shannon diversity index; a detailed 
description of alpha-diversity indices and application in microbiome research can be 
found by Li et al. (Li et al., 2012).  
1.2.2.1.7 Comparing samples 
Diversity between samples is often referred to as beta-diversity. At its simplest, samples 
can be compared by the OTUs shared, or by visualizing the relative abundance of 
different OTUs in a heatmap. A more detailed approach can be used that considers 
differences in species presence or absence, abundance, or phylogeny. This requires the 
use of multivariate analyses. Commonly used tools and some emerging techniques are 
described below.  For a more detailed description of the statistical background of many 
commonly used tools, the review by Remette et al. is helpful (Ramette et al., 2007).  
To begin to compare samples, a distance matrix is made that quantifies the differences 
between samples. This analyzes which taxa are present, and may or may not consider 
phylogeny or abundance of different species. Phylogeny-independent metrics treat all 
sequences equally regardless of their similarity. Sørensen's similarity matrices and the 
Jaccard index measure differences qualitatively by determining the distance between 
samples based on the presence or absence of OTUs.  The Bray–Curtis and Morisita 
similarity indices measure differences quantitatively based on the abundance of OTUs in 
each sample (Chao et al., 2006). These metrics do not consider differences in sequencing 
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depth, and so sequences must be normalized, or alternative methods that consider 
unobserved species must be used (Chao et al., 2006; Engen et al., 2011). Conversely, 
phylogeny-dependent metrics consider samples with more similar sequences to be more 
similar. This is done by first putting the reads on a phylogenetic tree. This can be 
constructed de novo by aligning and comparing samples, or by using a previously 
constructed reference tree. A good reference tree may more accurately represent the 
phylogenetic difference between species; however, a de novo tree will allow analysis of 
sequences that do not match anything on the reference tree. The most commonly used 
phylogeny-dependent similarity metric is the UniFrac distance. The unweighted UniFrac 
distance considers the similarity between sequences in the samples, but does not compare 
the sequences' abundances between samples, while the weighted UniFrac distance 
considers both the similarity between sequences and the sequences' abundances 
(Lozupone, Lladser, Knights, Stombaugh, & Knight, 2011). 
Once the distances between the samples can be determined, they can be compared by 
their similarities. One approach is clustering the data by similarity. Methods such as the 
neighbor-joining method or the unweighted pair-group method with arithmetic mean 
(UPGMA) can be used to arrange the distance data into clusters of samples, that can then 
be visualized as a dendrogram to show the samples that are most related. Squash 
clustering is a novel method that uses the Kantorovich–Rubenstein distance (in 
microbiome analyses this functions in a similar fashion as a weighted UniFrac distance) 
to cluster samples by their similarity, taking into account similarity and phylogeny; this 
method is available in the software package “guppy” (Matsen IV & Evans, 2013). Unlike 
other methods, in a dendrogram constructed by squash clustering the distance drawn 
between internal nodes (points that connect multiple samples) corresponds to the 
difference between them. 
Another approach to comparing samples is the use of principal coordinates analysis 
(PCoA). Here, the points (i.e., the samples) are plotted in multidimensional space so that 
the distance between them is as close as possible to that in the distance matrix calculated 
earlier. The direction in this multidimensional space that separates the points the most is 
the first principal coordinate, the direction that separates the points second best is the 
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second principal coordinate, and so on. Each principal coordinate has a percentage value 
associated with it that represents the percent of the variation explained by that dimension. 
One can plot the points where the axes represent the first and second principal 
coordinates (and for a three-dimensional plot, the third principal coordinate). This allows 
visualization of the distance data by reducing its dimensionality—points that cluster, in 
this case, have more similar microbiomes as determined by the distance matrix 
determined earlier. Points can be color-coded by metadata to qualitatively examine if 
different types of samples cluster or form gradients along any components.  Biplots can 
then be used to show the abundance of different taxa and in which samples these taxa are 
found. 
A variation of this method was published recently, called edge principal components 
analysis (edge PCA) (Matsen IV & Evans, 2013). Edge PCA uses a phylogeny-dependent 
distance metric that considers the relatedness of taxa, and the resulting principal 
components correspond to differences in particular clades of bacteria. This method 
produces an edge PCA plot that can be interpreted in a similar way to a PCoA plot. It also 
produces a phylogenetic tree of the organisms in the sample in which organisms that 
drive a given principal component have their edges color-coded (by whether they 
influence the principal component in the positive or negative direction) as well as having 
different thicknesses of the edges depending on how much they drive that principal 
component. This method is useful if differences in samples are driven by closely related 
taxa. Edge PCA can be performed using the “guppy” software package. 
The above methods are mainly exploratory. For more specific analysis, nonparametric 
hypothesis testing tools are implemented.  These include permutational multivariate 
analysis of variance (PerMANOVA, also referred to as nonparametric multivariate 
analysis of variance, NPMANOVA) (Anderson et al., 2001), analysis of similarity 
(ANOSIM) (Claerke et al., 1993), and the Mantel test (Mantel et al., 1967). These can be 
used with any distance metric to determine if the microbiome differs significantly 
between groups of samples. Recently, parametric tools have been developed to test 
hypotheses related to the microbiome, such as those found in the HMP R package. These 
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tools are more powerful than the nonparametric tests but generally require pooling rare 
taxa (La Rosa et al., 2012). 
1.2.2.1.8 Describing interactions between bacteria 
Amplicon sequencing and analysis can estimate the composition of different samples.  
Therefore, one can theoretically determine interactions between bacteria, for example, 
which bacteria co-occur and which co-exclude. However, this analysis is deceptively 
challenging. Since abundances of bacteria determined by these methods are proportional 
data, they are not independent; if one goes up, one or more others must go down. 
Standard measures of correlation assume that the data are independent, thus it is not valid 
to apply these to the proportional data, and doing so may result in spurious correlations 
(Aitchison et al., 1986). Because of this, specialized tools must be made for these 
analyses. 
There is currently no tool to analyze co-occurrence or co-exclusion that is frequently used 
in microbiome analysis, although some tools are under development. Faust et al. used a 
novel analytic technique to determine co-occurrence and co-exclusion and analyze the 
relationships' significance for human microbiome data; however, a computational tool to 
analyze data in the same way was not developed (Faust et al., 2012). Friedman and Alm 
produced a tool, SparCC (Friedman & Alm, 2012), that applies the log-ratio 
transformation (Egozcue et al., 2003) to transform proportional data into independent 
data and then approximates correlations to find co-occurring and co-excluding bacterial 
pairs. The problem of determining co-occurrence and co-exclusion based on abundance 
data is by no means resolved, and developing statistically sound methods that accurately 
represent and interpret these data is an active area of research. 
1.2.3 Future perspectives of high-throughput sequencing 
High-throughput sequencing technologies have improved in output and quality, and have 
become an indispensable tool for an increasingly wide variety of experiments, including 
in phylogenetic, diagnostic, and ecological contexts. Through these tools, scientists can 
gain insight into the composition, activities, and dynamics of a wide variety of 
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microbiomes.  This will help to elucidate how bacteria interact with each other and how 
they interact with their environment. 
Updates to the laboratory and computational tools are ongoing. In the near future, this 
will result in sequencers that require less handling (e.g., removal of the amplification 
step) in order to gain more automation and less error, while still maintaining high speeds 
and throughputs with low costs and error rates. On the computational side, tools are 
becoming faster and more specialized for multi-species samples, while also being able to 
investigate new questions such as differential expression from high-throughput RNA 
sequence data, genome assembly from metagenomic sequences, and interactions between 
bacteria from amplicon sequence data. Many of these tools have a steep learning curve 
for a biologist who is not computationally inclined, although specialized workflows are 
being developed to allow analysis of these data without extensive computational 
experience. As tools and statistical methodologies are refined, metagenomics and meta-
transcriptomics will be able to shift the focus of microbiome research from “Who is 
here?” to “What are they doing?”.  This will allow deeper insight into how bacteria 
interact with their environment and each other. Incorporation of metabolomes, nutrients, 
host genomes, and other metadata will allow the production of an incredibly detailed 
picture of interactions between the microbiome and its environment, helping us 
understand the role of prokaryotes in all environments in which they live.  
1.3 Functional anatomy of the urinary tract 
The urinary system dynamically exerts a cleaning and waste disposal function of the 
human body. It is composed of the upper urinary tract (kidney and ureter) and lower 
urinary tract (bladder and urethra). The two kidney resides bilaterally in the 
retroperitoneal space, surrounded by renal capsule, perirenal fat, Gerota’s fascia and 
pararenal fat. Being a bean-shaped organ, a kidney possesses a recessed area on the 
concave border called renal hilum, where the renal vasculatures and ureter enters. The 
kidney has high blood throughput, as it receives about 20% of the cardiac output, and 
filters approximately 150 liters of blood per day, the condensed output contributing about 
1.5 liters of urine after renal reabsorption, secretion and excretion. The urine is then 
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emptied into the minor calyces by renal papilla, collected into the major calyces and renal 
pelvis, and flows into the ureter. 
The two ureters are long, tubular structures that connect the kidney to the urinary bladder. 
The smooth muscle fibers in its wall form a peristaltic pressure wave that pushes the 
urine moving forward. The urine flow rate at the ureter is about 0.5 to 5 ml per minute. 
The ureteral peristalsis, together with the anti-reflux structure at ureterovesical junction 
warrants the unidirectional flow of urine.  This also serves as one of the defensive 
mechanisms of the urinary system against bacterial ascension to the kidney. 
The urinary bladder is a hollow organ located in the pelvis. It serves to contain urine,     
making periodic voiding by alternative functioning of its detrusor and sphincter muscles. 
Since the bladder is in close proximity to the exterior environment and urine in the 
bladder remains relatively stationary, the bladder is the most common site for adult 
urinary tract infections (UTIs). Because of this, the bladder possesses a vast catalogue of 
defensive mechanisms that resist bacterial adhesion and colonization. Commonly 
recognized lower urinary tract antibacterial defense mechanisms are listed in Table 2. 
The urethra is the final pathway before urine exits the human body. The length of the 
male urethra is approximately 20 cm while the female one is about 4 cm.  Although 
natural defenses against bacterial infection are present, the shorter urethral length in 
females is a major contributing factor to their increased vulnerability to UTIs.  Structural 
abnormality of the urinary tract remarkably compromises its natural resistance to 
bacterial invasion. Typically, urinary stasis is the direct result of the structural 
abnormality, and is the core cause of UTI. Common causes of urinary obstruction are 
listed in Table 3. Obstruction compromises the urine flow, and urinary stasis is a crucial 
risk factor or infection. Urinary stones are a common cause of urinary stasis. Hormonal 
and mechanical changes in the urinary system of pregnant women could lead to 
physiological urinary stasis, making them among highest risk groups in females. For 
males, the ones with congenital abnormalities and bladder outlet obstruction due to 
benign prostate hypertrophy are usually prone to obstruction to the free flow of urine. 
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Table 2. Antibacterial host defense mechanisms in the urinary tract (Jack D. Sobel, 
2015) 
Urine (osmolality, pH, organic acids) 
Urine flow and micturition 
Urinary tract mucosa (bactericidal activity, peptides, cytokines) - innate immunity 
Inflammatory response 
Polymorphonuclear neutrophils (PMNs) 
Tamm-Horsfall protein 
Cytokines 
Low-molecular-weight oligosaccharides 
Secretory immunoglobulin A (SIgA) 
Lactoferrin 
Peptides 
Adaptive immune system, humoral immunity 
Cell-mediated immunity 
Miscellaneous prostatic secretions 
Vesicoureteral reflux is another anomaly-associated risk factor for UTI.  Urine reflux 
contributes to upper urinary tract infection by promoting bacterial invasion via the 
ascending route and perpetuates infections by inducing postvoid residual urine.   
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Table 3. Common cause of urinary tract obstruction (Jack D. Sobel, 2015) 
Extrarenal obstruction 
Congenital anomalies of the ureter or urethra 
Valves 
Stenosis 
Bands  
Calculi  
Extrinsic ureteral compression 
Benign prostatic hypertrophy 
Intrarenal obstruction  
Nephrocalcinosis 
Uric acid nephropathy 
Analgesic nephropathy 
Polycystic kidney disease 
Hypokalemic nephropathy 
Renal lesions of sickle cell trait/ disease 
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1.4 Role of microbiota in recurrent urinary tract infections 
(rUTI) 
Urinary tract infections (UTIs) are the second most common bacterial infection in 
humans.  Of these, 20-25% of patients will experience a recurrence of their UTI (rUTI) 
(Bsrsv Foxman, 1990). This can lead to considerable morbidity and health care costs. 
Young, sexually active females are the most common sufferers of UTIs. About 50% of 
women will experience a UTI at least once throughout their lifetime, of these, 20-25% 
will experience rUTI and 3% will have this recurrence within six months following 
treatment (Foxman et al., 2000). Known risk factors for rUTI include hormone 
deficiency, diabetes, problems associated with urination, kidney stones and foreign 
objects within urinary tracts (e.g. ureteral stents). Another less widely known factor is the 
disruption of the vaginal microbiota, but it is believed this may also extend to other 
potential reservoir sites, such as the rectum (Bergeron et al., 2012). 
1.4.1 Etiology of rUTI 
The cause and etiology of rUTI may be quite different between patient populations. For a 
healthy young woman, the most common cause of rUTI is uropathogenic E.coli (UPEC) 
of rectal origin colonization in the vagina, periurethral and distal urethra (Stamey et al., 
1971).  Pediatric rUTIs are usually associated with conditions such as vesicoureteral 
reflux (VUR) (Conway et al., 2007). Male rUTIs are relatively rare and may be 
associated with urinary stasis following urinary tract obstruction, dysfunction and 
instrumentation. Bacterial colonization in prostate also contributes to male UTI 
recurrence (Carter, Levy, & Zeitlin, 2012). 
1.4.2 Reservoirs for rUTI 
 Pathogens of rUTI typically originate from the rectum, sometimes replacing the normal 
microbiota in the vagina. This occurs due to a state of microbiome flux, such as during 
bacterial vaginosis, which allows these pathogens to colonize the periurethral area, 
urethra and ascend into the bladder. Women with rUTI had a higher incidence of 
uropathogens colonizing in the vagina with longer duration and higher severity compared 
to women without rUTI, suggesting the role of the vagina in harboring uropathogenic 
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strains that constantly invades urinary tract (Brumfitt et al., 1987). In fact, as high as 68% 
of recurrences are caused by the same bacterial strain that caused the initial infection 
(Foxman et al., 2000).  It is documented that this same strain could take as long as three 
years after the initial UTI to cause recurrence (Gillespie et al., 2000).  In a normal vagina, 
bacteria are present to prevent pathogens from causing infection.  Lactobacillus crispatus 
and Lactobacillus iners are the predominant species (Burton & Reid, 2002). It is known 
these bacteria can prevent pathogens from multiplying to a symptomatic level by 
releasing lactic acid, hydrogen peroxide (H2O2), and neutralizing uropathogens via 
coaggregation effects (Reid et al., 1990). To cause initial infection, several daily 
activities may facilitate bacteria migrating from the rectum into the vagina; wiping from 
the anus towards the vagina after a bowel movement, retaining urine before voiding (i.e., 
not urinating when the initial urge is present), sexual intercourse and using a diaphragm 
or spermicide for birth control. Women who experience rUTI often have specific vaginal 
microbiota pattern shift.  There is an increased proportion of E. coli and depletion of 
normally predominant H2O2-producing lactobacilli (Gregor Reid et al., 2011). Although 
it is not known when this shift occurs, it is possible it is not a result of the infection but 
may predispose women to rUTI (Dwyer & O’reilly, 2002). 
1.4.3 Pathogens of rUTI 
Bacteria are the most common cause of UTIs, with UPEC causing the vast majority (up 
to 90%) of all diagnosed cases (Schmiemann et al., 2010). When the first infection is 
caused predominantly by E. coli, secondary UTIs may develop within six months due to 
other organisms (Scholes et al., 2000). Other common uropathogens include 
Staphylococcus saprophyticus, Enterococcus faecalis, Klebsiella pneumoniae, and 
Proteus mirabilis (Grabe et al., 2009). 
1.4.4 Pathophysiology of rUTI 
1.4.4.1 Bacterial adhesion 
Bacterial adhesion to host tissues serves as the first critical step in UTI pathogenesis. 
UPECs express a wide variety of virulence factors, including adhesion factors, 
hemolysin, siderophores and certain O antigens to exert their pathogenesis (Cadieux et 
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al., 2009). UPEC can express two types of pili that adhere to specific receptors on the 
uroepithelium. Interestingly, lactobacilli by-products have been shown to down-regulate 
genes associated with these functions in UPEC strains (McMillan et al., 2012). The type 
1 pilus adheres to mannosylated uroplakin proteins on the luminal surface of the bladder 
(Wright & Hultgren, 2006), while P pili bind to globoseries glycolipids on the kidney 
epithelial surfaces (Lane & Mobley, 2007). Some people are more susceptible to UTIs 
based on a variety of factors.  For example, individuals with an A, B, or AB blood type 
are known as “non-secretors” as they do not secrete the normal antigens for that blood 
type in bodily fluids. Non-secretors are more prone to recurrent UTIs because the cells 
lining the vagina and urethra allow bacteria to attach more readily (Kinane et al., 1982).  
1.4.4.2 Internalization and intracellular persistence of 
uropathogens 
 Traditionally, bacteria responsible for UTIs were thought to exert their pathogenesis on 
an extracellular basis. However, evidence now suggests UPEC strains encode 
mechanisms to invade or be internalized by the host bladder epithelial and kidney 
epithelial cells (Bishop et al., 2007). Similar invasive activities are observed in other 
uropathogens, including S. saprophyticus (Szabados et al., 2008), K. pneumoniae (Rosen 
et al., 2008), and S. enterica. Although the exact mechanism of invasion remains unclear 
and might differ between pathogens, bacteria also take advantage endocytosis by the 
epithelial cells (Bishop et al., 2007; Rosen et al., 2008). The pathogens avoid being 
expelled by exocytosis and escape the endocytic compartments to enter the cytoplasm 
(Eto et al., 2006). Once in the cytoplasm, they are able to multiply.  Protected from the 
host immune responses, pathogens can invade further into the underlying transitional 
epithelium to establish a quiescent intracellular reservoir (QIR) that can serve as the 
source of rUTIs (Hunstad & Justice, 2010). Studies based on murine models have 
reported that the bacteria within a QIR persist for months after initial UTI (Schilling et 
al., 2002), avoid host immune attack and systemic antibiotic therapy, and serve as the 
source for rUTI without re-inoculation into the bladder (Agace et al., 1993). 
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1.4.4.3 Immune evasion strategies of the pathogen 
Unlike many other organs, the immune response of the bladder is characterized by 
increased levels of urinary cytokines and neutrophil influx (Agace et al., 1993). This is 
dependent upon the innate immune responses (Nielubowicz & Mobley, 2010) rather than 
adapted responses (Chan, John, & Abraham, 2013). This, to some extent, explains why 
chronic and recurrent UTI is common. The bladders’ innate immune response is initiated 
by the activation of host pattern recognition receptors of the Toll-like receptor pathway, 
including Toll-like receptor 4 (TLR4) (Schilling, Martin, Hung, Lorenz, & Hultgren, 
2003). When urothelial cells expressing TLR4 recognizes lipopolysaccharide (LPS) from 
Gram-negative bacteria, the proinflammatory and prosurvival NF-κB pathway is 
activated, and chemokines/cytokines including IL-6 and IL-8 are secreted (Akira et al., 
2006). These inflammatory chemokines accumulate in the bladder mucosa and urine and 
further induce an influx of neutrophils into the bladder and in turn phagocytosis and 
clearance of bacteria. Though UPEC was reported to induce an adaptive immune 
response in murine models (Thumbikat et al., 2006), pathogen-specific antibodies cannot 
be detected in the serum and urine of patients with bladder-restricted infection 
(Thumbikat et al., 2006). 
Uropathogens can suppress inflammatory responses activated via TLR4 and other 
receptors on the epithelial and bladder-resident immune effector cells. UPEC is able to 
stabilize IκB and suppress NF-κB activity, thus hampering the increased apoptosis of 
bladder epithelial cell upon exposure to UPEC (Klumpp et al., 2001), lowering 
expression levels of IL-6 and IL-8, and suppressing secretion of these cytokines (Klumpp 
et al., 2001). UPEC was also reported to downregulate the neutrophil gene related with 
inflammatory signaling and in neutrophil chemotaxis, adhesion, and migration, thus 
delaying neutrophil influx during very early stages of infection, facilitating bacterial 
internalization (Klumpp et al., 2001). Interestingly, clinically isolated UPEC strains are 
less susceptible to neutrophil killing in vitro and more resistant to reactive oxygen species 
(ROS) and antibacterial peptides released by polymorphonuclear leukocytes and other 
host cells in response to UPEC infection (Klumpp et al., 2001).  
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1.4.5 Role of microbe in management for rUTI  
1.4.5.1 Lactobacillus probiotics for rUTI 
 Since depletion of normal vaginal H2O2-producing lactobacilli is associated with 
increased risks of UTI and recurrence, it seems to be a reasonable strategy to replete the 
normal vaginal microbiota with lactobacilli to reduce the risk of UTI. Certain 
Lactobacillus and avirulent E. coli species have been studied for their probiotic potential 
(Barrons et al., 2007). Various clinical trials have reported to restore the protective 
vaginal microbiota via oral (Beerepoot et al., 2012), intravaginal (Baerheim et al., 1994; 
Reid et al., 1992; Reid et al., 1990) and direct intravesical delivery for rUTIs (Hagberg et 
al., 1989). When studies using ineffective strains or testing for safety were excluded, 
most studies have confirmed a reduced recurrence rate in patients receiving 
Lactobacillus-containing probiotics. Individuals receiving intravaginal probiotic therapy 
seemed to have a lower recurrence rate, and those who did recur did so on a longer 
interval between episodes (Stapleton et al., 2011). These studies showed the importance 
of maintaining good vaginal ecology for preventing rUTI. Although probiotic treatment 
might generally have a slightly inferior therapeutic effect (Beerepoot et al., 2012) when 
compared to traditional long-term antibiotic prophylaxis, this antimicrobial-sparing, well-
tolerated strategy could possibly reduce the UTI-associated costs and morbidity, 
including time lost from work, health care costs, antimicrobial use, and the ultimate 
development of antimicrobial resistance (Russo & Johnson, 2003). More evidence with 
larger sample size and validated dosing strategies are needed to confirm the efficacy of 
this approach. 
1.4.5.2 Future probiotics and microbial therapies 
Currently, a dilemma exists over antibiotic usage in rUTI management and the 
development of alternative therapies, including probiotics. This is because many of these 
alternative therapies are susceptible to antibiotic use. Besides the probiotic agents 
mentioned above, several strategies have been undertaken to develop new probiotics 
including developing avirulent E.coli strains, new lactobacilli and other strains. Avirulent 
E.coli strains (i.e., strains few virulence markers of adhesion, specific O and K serotypes, 
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hemolysin production, and resistance to serum effects) could serve as competitive 
colonizers of the bladder (Hagberg et al., 1989). When instilled into the bladder, they 
colonized the mucosa and may interfere with the onset of symptomatic infection. 
Instillation of avirulent E. coli 83972 into the bladders successfully created a long-term, 
antibiotic-resistant colonization that reduced symptomatic infection (Hull et al., 2000). 
Another strain, E.coli Nissle 1917, has been verified by previous studies for its ability to 
colonize the bowel, displacing gut pathogens as well as boosting the innate immune 
response of the gastrointestinal tract (Henker et al., 2008). Recent in vitro studies have 
observed the ability of E. coli Nissle 1917 to eradicate or out-grow ~75% of known 
uropathogens, suggesting its potential of being used as a urinary probiotic.  
The horizon of Lactobacillus-containing probiotics is continuously being widened. 
Besides its abilities to restore the normal vaginal microbiota and prevent UTI, recent 
studies reported that L.rhamnosus GR-1 was able to strengthen the immune response of 
the urinary system (Karlsson et al., 2012), and that oral application of Lactobacillus 
mixture on pregnant mice would reduce the risk of UTI on the newborn (Lee et al., 
2013). It is also quite possible that new strains of Lactobacillus, both natural and 
genetically-modified, together with other bacterial species, could be applied for rUTI 
prevention. 
Even if there is a predisposition to having UPEC at sites beyond the urogenital tract, such 
as the colon and rectum, probiotics and other microbiota modifying therapies may reduce 
microbial carriage and subsequent reinfection risk. While extreme therapies such as fecal 
transplant are becoming more common for chronic intestinal infections, such as recurrent 
Clostridium difficile, such therapies will not be adopted quickly for UTI (Ettinger et al., 
2013). If more was understood about the microorganisms that naturally occupy the 
bladder, their role in maintaining a homeostatic environment, immunomodulatory effects 
and direct antagonistic effects on pathogens, a probiotic or “synthetic urine” treatment to 
restore the “healthy” bladder microbiota might exist.   
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1.5 The urinary microbiota: the uncultivable side 
 Urine was once considered sterile and only contained bacteria during infection.  For 
most clinicians, the presence of bacteria in urine is a pathological condition with its 
severity varying from a mild asymptomatic bacteriuria to a lethal urosepsis. Such ideas 
are formed due to the fact that culture-based techniques remain as the “gold standard” for 
microbial pathogen detection for clinical practice. However, recent studies have shown 
that although commonly used methods for clinical sample culture are effective at 
detecting fast-growing pathogenic bacteria, it will neglect some slow-growing, fastidious 
commensal microbial species for which their role in disease prevention and homeostasis 
has not yet been determined. With the introduction of high-throughput DNA sequence-
based techniques, several studies have identified evidence of commensal microbial 
communities in the urinary bladder, especially in female populations. Wolfe et al. was the 
first reported evidence of uncultivated bacteria in the urinary bladder (Wolfe et al., 2012). 
Since then, multiple studies have investigated the urinary microbial communities using 
sequencing-based techniques among various populations, as demonstrated in Table 4. 
Guided by the sequencing results, enhanced culture methods based on increased sample 
volume, extended culture time, a wide spectrum of media and atmospheric conditions 
were developed that could isolate and identify many urinary microorganisms that 
traditional culture does not (Hilt et al., 2014). Although still preliminary, these studies 
have shown that the urinary microbiota significantly differs between male and females, 
with the female microbiota containing higher abundance and greater diversity, which was 
undoubtedly associated with microbial ascension from the lower genital tract (Wolfe & 
Brubaker, 2015).  These discoveries have drawn interest in exploring the association of 
urinary microbiota with several urinary conditions 
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Table 4. published studies characterizing the urine microbiota in human 
populations 
Study Patient Demographics Sample Collection 
Method 
Nelson et al., 2010  Males with STI (n=10) 
Males negative for STI (n=9) 
First-void urine 
Dong et al., 2011  Males with STI (n=10) 
Males negative for STI (n=22) 
First-void urine 
Siddiqui et al., 2011 (  Healthy females (n=8) Clean-catch midstream 
urine 
Fouts et al., 2012  Healthy controls (n=26; 
females=58%) 
Neurogenic bladder patients 
(n=27, female=48%) 
Midstream urine, 
Intermittent 
Catheterization, Foley 
Catheter 
Nelson et al., 2012  Healthy adolescent males (n=18) First-void urine 
Siddiqui et al., 2012  Females with IC (n=8) Clean-catch midstream 
urine 
Wolfe et al., 2012  Healthy females (n=12) 
Females with pelvic organ 
Clean-catch midstream 
urine, suprapubic aspirate, 
transurethral catheter 
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prolapse or urinary incontinence 
(n=11) 
Lewis et al., 2013  Healthy males (n=6) 
Healthy females (n=10) 
Clean-catch midstream 
urine 
Fricke et al., 2014  First renal transplant patients 
(n=60; females=37%) 
Not described 
Hilt et al., 2014  Healthy females (n=24) 
Females with overactive bladder 
(n=41) 
Transurethral 
catheterization 
Pearce et al., 2014  Healthy females (n=58) 
Females with urgency urinary 
incontinence (n=60) 
Transurethral 
catheterization 
Willner et al., 2014  Acute uncomplicated UTI 
patients (n=50; females=76%) 
Midstream urine 
Horwitz et al., 2015  Aged adults with chronic urethral 
catheter (n=11, male = 82%) 
Urethral catheter section 
Thomas-White et al., 2015  Healthy females (n=60) 
Females with urinary urgency 
incontinence (n = 74) 
Transurethral 
catheterization 
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Shoskes et al., 2016   Chronic Prostatitis/Chronic Pelvic 
Pain Syndrome patients (n=25) 
Healthy males (n=25) 
Midstream urine 
Karstens et al., 2016   Female urinary urgency 
incontinence patients (n=10) 
Healthy females (n=10) 
Transurethral 
catheterization 
Modena et al., 2017  Renal transplantation patients 
(n=25) 
Healthy individuals (n=20, males 
= 50%) 
Midstream urine 
Groah et al., 2016  Neuropathic bladder patients 
(n=24) 
Healthy controls (n=23) 
Midstream urine 
Rani et al., 2016  Renal transplantation patients 
(n=21) 
Healthy controls (n=8) 
Midstream urine 
Gottschick et al., 2017  Women with BV/receiving 
treatment (n=109/43) 
Midstream urine 
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Healthy controls (n=80 
male=39%) 
Shrestha et al., 2017  Prostate cancer patients (n=65) 
Males with benign prostate 
(n=65) 
Midstream urine 
 
1.6 Common urinary conditions and their association with 
the urinary microbiota 
Multiple studies have suggested that the human urinary microbiota may contribute to 
symptoms or pathogenesis of many urinary conditions. As initially reported by Wolfe et 
al., the commensal urinary microbiota can be detected by both sequencing-based and 
enhanced culture methods (Hilt et al., 2014, Wolfe et al., 2012), and are clearly different 
form contaminating microorganisms and pathogens causing UTI (Nienhouse et al., 2014, 
Siddiqui et al., 2011). Pearce et al. examined the urinary microbiota of females with 
urgency urinary incontinence and found several bacterial species more common in the 
diseased state than in healthy controls, including Actinobaculum, Actinomyces, 
Aerococcus, Arthrobacter, Corynebacterium, Gardnerella, Oligella, Staphylococcus, 
Streptococcus and L.gasseri (Pearce et al., 2014). Siddiqui et al. used 454 
pyrosequencing to investigate urine samples from women with interstitial cystitis and 
found a remarkable increase in Lactobacillus together with decreased microbial diversity 
(Siddiqui et al., 2012). Fouts et al. compared urinary microbiota pattern of patients with 
spinal cord injury and found Lactobacillales, Enterobacteriales, Actinomycetales, 
Bacillales, Clostridiales, Bacteroidales, Burkholderiales, Pseudomonadales, 
Bifidobacteriales, and Coriobacteriales to be the most abundant bacterial taxa (Fouts et 
al., 2012). 
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1.7 Questions and challenges associated with studying the 
microbiota of the urinary tract 
1.7.1 Common questions of urinary microbiota studies 
1.7.1.1 What do they do in the urinary tract? 
The urinary microbiota shares some similarities with microbiota of the lower genitalia, 
but with a lower abundance. Questions have been raised about the function of these 
commensal urinary microbes. In the lower urogenital tract, such as the vagina, it is 
known that certain bacteria act as sentinels and protectors against potentially dangerous 
microorganisms that may ascend further and cause an infection, such as UTI (Beerepoot 
et al., 2012; Beerepoot et al., 2016). It is not known if or how the microbiota may play a 
protective role in the bladder, but it is assumed that the lower urogenital tract is the 
gateway to this region.  Studies demonstrating probiotic treatment to the urogenital tract 
reduces UTI recurrence rates supports this idea (Beerepoot et al., 2016).  The numbers of 
commensal bacteria in the bladder are thought to be considerably less than the lower 
genital tract, and several remain to be cultured(Whiteside et al., 2015). Even though 
bacterial numbers are lower in this region, they still have the potential to out-compete 
pathogens for necessary nutrients, produce antimicrobial substances and stimulate the 
immune system. 
Where bacteria colonize other human surfaces, they play a key role in the homeostasis of 
the mucosal environment and numerous studies detail these on skin, buccal cavity, nasal, 
small intestine, bowel, lung and vaginal interactions (Cosseau et al., 2008; Dickson et al., 
2015; Hummelen et al., 2011; Lopetuso et al., 2014; Pfefferle & Renz, 2014; SanMiguel 
& Grice, 2015). It makes sense to presume that even while there may be fewer bacteria in 
the urinary system than many other colonized sites, these microorganisms still play a 
significant role in the maintenance of the uroepithelium.  
1.7.2 Is the urinary microbiota associated with urinary malignancy? 
The theory of inflammation causing bladder cancer dates back to Virchow’s report in 
1860 (Virchow & Chance, 1860) and presently remains under controversy. Multiple 
epidemiological studies have looked at the association between UTI and bladder cancer 
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yielding conflicting results (Abol-Enein et al., 2008; Hartge et al., 1990; Kantor et al., 
1984; Kjaer et al., 1989; Pelucchi et al., 2006; Pisani et al., 1997). It is understandable 
since most studies have relatively small sample size, and had a cross-sectional or 
retrospective design. Vermeulen et al. investigated 1809 bladder cancer patients and 
compared their data to 4370 control participants. The results showed that regular cystitis 
is a contributing risk factor for bladder cancer, and this risk may be alleviated by 
receiving antibiotics for UTI treatment (Vermeulen et al., 2014). It is with the hope that 
the introduction of meta-omics techniques could shed further light on this mystery.  
1.7.2.1 How far up the urinary tract do bacteria go and how 
commonly are they found in the kidney? 
 While urine passes from the kidney through the urological system to exit in the external 
environment, the kidney is not typically considered to be routinely occupied by bacteria. 
Under pathological conditions such a severe UTI or urine reflux, bacteria may invade the 
kidney by an ascending route causing pyelonephritis, pyonephrosis, and urosepsis. 
Urinary stasis caused by obstructions of the upper urinary tract also predisposes the 
kidney to bacterial infection. However, in case of upper urinary obstruction such a stone 
in the upper ureter, there are no factors promoting bacterial ascending, making it difficult 
to explain the source of bacteria in the kidney with current theories. In preliminary 
studies looking at the microbiota within kidney stones, it appears that bacteria can be 
detected both by culture and non-culture microbiological techniques (Barr-Beare et al., 
2015). Interestingly, preliminary data of five pediatric subjects suggests that bacteria may 
be detected as far as the kidneys and may be present within the kidney stones themselves. 
The nidus for kidney stone formation and precipitation from urinary supersaturation is 
thought to be inflammation. The potential for bacteria to cause this is one possibility and 
in murine studies, it was shown that the presence of calcium oxalate deposits increases 
pyelonephritis risk, likely due to preferential aggregation of bacteria on and around 
calcium oxalate crystals (Barr-Beare et al., 2015). 
36 
 
 
1.8 Microbiota investigations of human tissue with low 
microbial biomass 
While the urological system has been shown to have bacteria within it, these bacteria are 
in relatively small numbers compared to other sites occupied by bacteria in the human 
body (Lewis et al., 2013). The processing and handling of samples with low microbial 
biomass are much more challenging than conventional microbe-rich samples as the 
sequencing results can be overshadowed by “noise” reducing the reliability when 
studying a microbiota of interest. Reagent contamination is a known issue for molecular 
biology experiments (Champlot et al., 2010; Shen et al., 2006), it is also recognized in 
metagenomics studies (Glassing et al., 2016). In 2014, Salter et al. showed a serially 
diluted pure culture of Salmonella bongori samples then subjected to DNA extraction, 
16S rRNA gene amplification and sequencing yields growing the proportion of 
background noise in sequencing reads as the dilution proceeds. The number of PCR 
cycles also affected sequencing quality. For samples with low microbial biomass, 20 
cycles were too low to generate sufficient amplicons while 40 cycles generated too much 
noise (Salter et al., 2014). The optimal PCR cycle number may need to be optimized for 
each sample type or batch of samples. On the other hand, Kennedy and colleagues 
showed that the template concentration in samples, i.e., the input microbial biomass, also 
affected sequencing quality, weakening the microbial vs. background ratio (Kennedy et 
al., 2014). Since then, multiple studies have confirmed the existence of inherent bacterial 
DNA in reagents and environment, contributing contaminating microbes to a total 
number of 181 genera (Glassing et al., 2016; Shen et al., 2006; Weiss et al., 2014). The 
term “kitome” or “contaminome” was then introduced to describe these contaminating 
reagent microbial DNA (Dickson et al., 2017; Kverka et al., 2017). The kitome differs by 
manufacturer and model, kit batch, and even in different tubes or lots of one product 
(Glassing et al., 2016; Weiss et al., 2014). Therefore, it is crucial to process all samples 
in a project in a short period, preferably using one kit if possible. Recording the type of 
kit used, together with its batch number is strongly recommended. In case multiple kits 
were required to be used, it should be taken into the potential confounding factors for 
statistical analysis. 
37 
 
 
In this thesis, another confounding factor was analyzed.  The host DNA that is present in 
the sample may affect sequencing results, especially in case of samples with high host-, 
low microbial biomass (“high-low samples”). When quality-checking samples, the host 
DNA abundance should also be taken into consideration, rather than only evaluate the 
microbial vs. background/reagent ratio as most previously published article has done. 
This analysis will be further discussed as a major component of the second chapter.  
1.9 Scope and objectives of the thesis 
In this thesis, the microbiota of the human urinary tract was investigated. Multiple trials 
were conducted to collect various clinical sample including urine and surgical tissue 
samples from the urinary system. There are a limited number of studies looking at the 
urinary microbiota, and at the onset, none have analyzed their sample handling 
techniques and potential confounding factors. To our knowledge, there is no published 
data of microbiota of renal tissue, and urine of stone and bladder cancer patients. The 
general hypothesis is that a dynamic microbiota exists in the urinary tract and these 
microbial shifts exhibit different phenotype across various urinary conditions. Since the 
method of studying the urinary microbiota has yet to be standardized, this was the first 
step to develop and optimize algorithms for urinary tissue microbiota and urine 
microbiota. This methodology was used in Chapter 2, 3, 4 to handle “high-low” samples. 
Samples with low microbial biomass are recently reported to be vulnerable to reagent 
contaminations, and in Chapter 2 this was further examined to show that the presence of 
host DNA could exert negative effects on sequencing results on multiple levels. A refined 
protocol was developed and utilized in renal microbiota profiling in a later section of 
Chapter 2. In chapter 3, we focused on characterizing the urinary microbiota of a healthy 
individual and urinary stone patients and investigated the stability of urinary microbiota 
by analyzing several temporally discrete samples from the same donor. In Chapter 4, we 
observed fluctuations of urinary microbiota during lithotripsy surgeries in urinary stone 
patients to examine the possible existence of bacteria in metabolic urinary stones. 
Overall, these studies constitute a comprehensive picture of the urinary microbiota in 
various conditions. The following studies have generated multiple methods and 
techniques for microbiota research in sites without a rich microbial community. The 
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importance of understanding the potential pitfalls of microbiota research is underscored, 
and this thesis will provide further insight into future techniques of carrying out such 
studies. 
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Chapter 2  
2 Optimization of methodology of handling samples of 
high host and low microbial biomass reveals the renal 
microbiota 
2.1 Introduction 
Through culture-independent microbial identification protocols, microbiota studies have 
demonstrated that a rich and diverse microbial community inhabits in the human body, 
varying in its structure, abundance and function depending on body sites (Costello et al., 
2009; Ding & Schloss, 2014; Segal & Blaser, 2014). The microbes inhabiting these sites 
have been found to play critical roles in maintaining the normal function of host 
metabolism (Bäckhed et al., 2004), hormone regulation (Markle et al., 2013) and even 
psychological status (Hsiao et al., 2013). Additionally, certain microbiota profiles have 
also been associated with numerous conditions including diabetes mellitus, inflammatory 
bowel diseases, and multiple sclerosis. (Berer et al., 2011).  
As the exploration of microbiota-associated diseases continues, a growing number of 
studies have been carried out to investigate the microbiota in sites with comparatively 
low microbial abundance. These include the brain (Branton et al., 2013), breast 
(Urbaniak et al., 2014), atherosclerotic plaques (Koren et al., 2011), placenta (Aagaard et 
al., 2014), blood (Potgieter et al., 2015) and from an important urological perspective, the 
bladder (Wolfe et al., 2012). Detection of bacterial DNA sequences in these sites 
questions the concept of sterility, and the role of bacteria within the body. However, 
before drawing such conclusions, sampling bias, DNA contamination, and accuracy of 
microbiota data analysis must be addressed.   
The first definitive description of the bladder microbiota was only undertaken relatively 
recently, by the direct collection of urine aspirated supra-pubically in an attempt to 
discount urogenital contamination of specimens (Wolfe et al., 2012). This discovery 
challenged the dogma that the urinary tract is sterile. Several other studies also confirmed 
an existant microbiota in the bladder and associated it with various conditions including 
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incontinence, interstitial cystitis and neurogenic bladder (Pearce et al., 2014; Siddiqui et 
al., 2012; Groah et al., 2016). Although the exact association of the urinary microbiota of 
these conditions remains to be elucidated, it has gradually come to people’s awareness 
that a viable urinary microbiota, although unable to be detect by routine culture methods, 
exist in the bladder. 
However, whether microorganisms exist in the upper urinary tract remains unclear. To 
date, there’s no study looking specifically at urinary microbiota of the upper urinary tract 
in asymptomatic individuals without infective conditions. However, the ascension of 
bacteria through the urinary tract beyond the bladder causing infections such as 
pyelonephritis have also been commonly reported (Andersen & Jackson, 1961), 
suggesting the possibility of bladder microbiota ascending to the upper urinary tract. On 
the other hand, asymptomatic infections do occur in the upper urinary tract (Dontas et al., 
1981; Kass et al., 1972), which could be originated from the microbiota of the upper 
urinary tract among asymptomatic individuals.  
Applying the novel sequencing-based techniques to the study of urinary microbiota is not 
without difficulties. One of the technical challenges of studying the microbiota of the 
upper urinary tract is sample collection. It is difficult to obtain kidney samples for 
microbiota analysis due to the invasiveness of procedures. This is especially true for 
obtaining samples from healthy individuals. The use of renal tumour and “healthy” 
adjacent tissue samples offers the opportunity to examine the microbiota without added 
morbidity to the patient. Samples of tissue are excised during nephrectomy. This setting 
also allows for comparison of the microbiota of tumour and healthy renal tissue. 
Another technical challenge is the sample handling. Given that renal tissue samples have 
much lower microbial abundance, sample processing and analysis protocols taken 
directly from gut microbiota studies have not been properly validated. Problems not 
considered are relating to factors which are associated with the high proportion of host 
DNA that is present in the sample must be taken into consideration. 
In this study, protocols were developed for analyzing low microbial abundance samples 
in tissue. These protocols were optimized and compared to standard protocols. The aim 
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was to determine whether renal tissues had a detectable microbiota and if it was different 
within tumours compared to healthy tissue sites.   
 
2.2 Methods 
2.2.1 Cell lines and bacterial strains 
Transitional cell carcinoma-derived human 5637 cells were obtained from the American 
Type Culture Collection (ATCC® HTB-9™, Manassas, VA, USA). Cells were cultured in 
RPMI-1640 with 10% fetal bovine serum plus 2 mM glutamine. E. coli DH5α cells were 
maintained on Luria-Bertani (LB) medium containing 1.5% agar (LB agar). When 
required, a single isolated colony was transferred into LB medium and grown overnight 
at 37℃ on LB with continuous shaking. Gardnerella vaginalis (ATCC® 14018™) was 
maintained on Columbia blood agar (CBA) containing 5% sheep blood. When required, a 
single isolated colony was transferred into Brain Heart Infusion (BHI) broth and was 
grown overnight at 37℃ with continuous shaking. 
2.2.2 Sample collection 
Biological materials, including paired tumour and control “healthy-adjacent” tissue 
samples from fifty-six donors, were provided by the Ontario Tumour Bank, which is 
funded by the Ontario Institute for Cancer Research. Ethical approval for the study was 
granted by the University of Western Ontario Human Ethics Committee and Lawson 
Health Research Institute (protocol number HSREB 104309). The samples included 
tumour tissue and a control specimen consisting of an adjacent non-tumorous tissue, 
approximately 4 cm away from the tumour. Tumor samples represent various grades and 
pathologies, as shown in the appendix. Sample size varied from approximately 0.2 to 1 
cm3. These were aseptically transferred into cryogenic vials and stored at -80°C until 
further analysis. 
To collect bacterial samples from the exterior of the tumour tissue, the entire tissue mass 
was transferred to a 2 ml microcentrifuge tube containing 1 ml DNA-free phosphate-
buffered saline (PBS, pH 8.0). The samples were placed in a sonicating water bath 
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(Branson® Ultrasonic Bath Model 1200) at 60 Hz for 5 minutes then vigorously for 1 
minute. The remaining liquid was enriched for any bacteria present on the surface. These 
samples underwent the standard DNA extraction protocol developed for the other tissue 
samples.  
2.2.3 Tissue surface decontamination and fragmentation 
Specimens were aseptically transferred to 20 ml of DNA-free PBS and vortexed for 20 
sec. The PBS was removed, and 20 ml of DNA-free 75% ethanol was added for 3 
minutes, followed by 20 ml of 5% bleach for 1 min, 75% ethanol for 2 min and finally 
five wash cycles of DNA-free PBS. The samples were then centrifuged, discarding the 
supernatant and then homogenised using a DNA-free microtube and pestle (Kimble-
Chase Kontes™ Pellet Pestle™, Fisher Scientific). PBS was then added a final 
concentration of 0.4g tissue/ml. The tissue lysate, together with all the surface control 
samples, were used for routine culture, EQUC and DNA extraction for 16S rRNA gene 
sequencing. Five reagent controls were taken during the experiment (including PBS, 
water, DNA-extraction and PCR amplification reagents). Samples were stored at -80℃ 
until further analysis. 
2.2.4 DNA extraction 
When required, tissue homogenates were thawed on ice, and the DNA was extracted. 
Tissue was homogenized using the manufacteurer’s protocol specific to the MOBIO 
PowerSoil® 96 well Kit and Qiagen QIAamp kit. For the refined protocol, ethanol 
precipitation was applied instead of the conventional filter binding protocol.  
2.2.5 gDNA copy number estimation 
In pure culture samples, the gDNA copy number was estimated by Qbitz (Qiagen, 
Mississauga, ON, Canada) and nanodrop (Thermo Scientific). For mixed samples the 
E.coli DH5a gDNA copy number was estimated by qPCR quantification. To ensure the 
accuracy of qPCR quantification NEBnext® Microbiome DNA Enrichment Kit (New 
England Biolabs, Beverly, MA, USA)was used to remove host DNA and enrich E.coli 
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DNA. The DNA samples were then serially diluted to confirm an optimal Ct value to 
avoid potential inhibition.of amplification 
2.2.6 PCR amplification 
Extracted DNA from the clinical samples were PCR-amplified with barcoded primers as 
described by Gloor et al. (2010) shown in Appendix A. The PCR was performed in a 42-
μl reaction system, with details listed in Appendix B. Following PCR, the amplicons 
were quantified with the Qubit 2.0 fluorometer (Invitrogen, CA, USA). Equimolar 
amounts of each amplicon were aliquoted into a single tube purified with the QIAquick 
purification kit (Qiagen, Mississauga, ON, Canada). Each product was then pooled and 
sequenced on the Illumina Mi-Seq platform in a paired-end run using a 600 cycle kit with 
a paired-end 220-bp run at the London Regional Genomics Center (Robarts Research 
Institute, London, ON, Canada), following standard operating procedures. 
2.2.7  Sequence processing and taxonomic assignment. 
Description of the processing algorithm has been previously published (Gloor et al., 
2010). The SOP and related software are accessible at 
http://github.com/ggloor/miseq_bin. The sequences were processed following algorithm 
as stated in Appendix C. Paired-end reads were overlapped with Pandaseq V2.5 (Masella 
et al., 2012), allowing no ambiguous positions in the overlapped reads. Reads were then 
demultiplexed and tagged with the name corresponding to the sample identifier and 
barcode. After demultiplexing, reads from all samples were merged into one single file 
and were clustered into individual sequence units (ISUs), which were then further 
grouped into operational taxonomic units (OTUs) with open reference OTU picking 
method, using Uclust algorithm of USEARCH version 7, which has a de novo chimera 
filtering step built into it (Edgar et al., 2010; Edgar et al., 2015). The identity threshold 
was 97%. Singleton OTUs and ones with abundance < 1% were discarded. Taxonomical 
assignment was performed with mothur 1.3.4 to annotate the OTU sequences against the 
Silva database (v119). 
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2.2.8  Data analysis 
For data exploration, OTUs with a zero value was replaced by a small numerical value 
with the count zero multiplicative methods in the zCompositions package (Palarea-
Albaladejo et al., 2015). Custom R codes were generated to perform centered log ratio 
(clr) transform of the zero-replaced data set. Then a singular value decomposition (SVD) 
was applied to the data. The output was used for PCA plots exploration. 128 Dirichlet 
Monte-Carlo (DMC) instances from the data with clr-transform were used for 
quantitative data analysis. ALDEx 2 V.1.6.0 package were used for differential 
abundance test. Significance was based on the Benjamini-Hochberg corrected P value of 
the Wilcoxon rank test (significance threshold P < 0.1). 
2.3 Results 
2.3.1 High host cell abundance is associated with poor microbial 
DNA yield and microbial community representation in 
column-extracted DNA samples 
DNA extraction kits typically use silica gel membranes to bind sample DNA. The MO 
BIO Powersoil® kit, one of the most widely used DNA extraction kits for microbiota 
analysis, was tested for the maximal DNA yield of E. coli DH5α cells in the presence of 
human bladder 5637 cells. The Powersoil® kit and subsequent detection of bacterial DNA 
via qPCR allowed for more than 109 copies of E.coli gDNA to be detected when 1010 
copies of E.coli gDNA was inputted. However, 1010 copies of bladder 5637 cells would 
only generate around 106 copies gDNA in the product. (Figure 2a). A similar 
phenomenon was observed when Qiagen QIAamp® DNA Stool Mini Kit, another 
common kit used for bacterial genomic extraction, and where DNA was inputted instead 
of cells for both extraction kits (Figure 3a, 4a, and 5a). When a mock sample of mixed E. 
coli DH5α cells and bladder 5637 cells went through DNA extraction, the microbial 
gDNA yield of the mock sample started to drop when bladder 5637 cell number exceeded 
104, (Figure 2b, 3b, 4b, and 5b). However, when the final kit collection steps involving 
the silicon-embedded filters were substituted for ethanol precipitation, the “column 
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saturation effect” of the 5637 cell DNA yield was reduced (Figure 2c, 3c, 4c and 5c), and 
a higher microbial DNA detection/ recovery was observed from the mixed mock samples 
(Figure 2d, 3d, 4d and 5d). It appears that column-based DNA extraction methods have 
poorer microbial DNA yields in the presence of highly abundant host DNA reducing the 
sensitivity of its detection. 
To investigate if the microbial DNA recovery rate is associated with microbial sampling 
bias and poorer microbiota representation, “mock” or simulated community samples with 
six bacterial strains were combined with increasing numbers of bladder 5637 cells. These 
samples were then DNA-extracted with the Powersoil® kit. Extracted DNA was then 
amplified with primers specific for the V4 region of the 16S rRNA gene and sequenced. 
Analysis demonstrated that in mock samples starting with equal numbers of each 
bacterial type, when the host gDNA present exceeds 105 copy/sample, the bacterial 
community representation was severely compromised (Figure 6). In summary, silicon 
columns-based DNA extraction methods have a limited DNA yield and may compromise 
microbial DNA yield with abundant host DNA in the sample. 
2.3.2 Effect of background DNA on microbial DNA amplification 
and sequencing analysis 
Background DNA from host tissue could be another factor which potentially hampers the 
PCR amplification and quality of downstream analysis. To look at the impact of this, a 
series of extractions containing increasing concentrations of bladder 5637 gDNA with a 
constant amount of E. coli DH5α gDNA was created. The bacterial gDNA copy was then 
estimated with qPCR. The results indicated that the amplification efficiency started to 
decrease when 103 copies of 5637 bladder cell gDNA were present and became severely 
inhibited above 3.5 x105 copies (Figure 7a). Dilution of sample concentration could help 
mitigate the inhibitory effect, as shown in Figure 7b, where when a mock sample with 
109 copies of E. coli gDNA and 105 copies of bladder 5637 gDNA receive a hundred-fold 
dilution, the Ct difference to the mock sample with same microbial biomass but no 
bladder gDNA dropped from 3.12 (12.57 vs 9.45) to 0.06 (15.72 to 15.66). Similarly, a 
100-fold dilution of a mock sample with 107 copies of E. coli gDNA and 105 copies of 
bladder 5637 gDNA reduces the Ct difference from 4.46 (20.12 vs 15.66) to 0.64 (23.49 
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vs 22.85) (Figure 7b). When observing the 16S rRNA gene sequencing results with mock 
microbial samples combined with 5637 bladder cell gDNA, the microbial composition 
becomes proportionally distorted with higher the background DNA present. This 
distortion occurred when DNA abundance was under 105 copies/ ml in the template, or 
when host gDNA concentration was 1000 times higher in copy numbers than microbial 
gDNA (Figure 7c and 7d). To mitigate inhibitory effects of host DNA during the PCR. 
We tried to use a commercial host DNA removal kit (NEBnext® Microbiome DNA 
enrichment Kit) to remove host DNA. However, the host DNA remained, especially in 
conditions where a high amount of host DNA was present (Figure 8 and 9a). 
 
Figure 2 Effect of host cells in the sample on microbial DNA yield. In this plot, E.coli 
DH5a cells or bladder 5637 cells (for a and c) or their mixtures (for b and d) at various 
amounts received DNA extraction with MO BIO Powersoil® kit standard protocol (for a 
and b) or adapted protocol, with the last collection steps involving the silicon-embedded 
filters were substituted by ethanol precipitation (for c and d). X-axis shows sample cell 
number, Y-axis shows estimated DNA copy number after DNA extraction with qPCR 
(for E.coli DH5a cells) or DNA fluorometer and spectrophotometer (for bladder 5637 
cells). (a) DNA yield of E.coli DH5a cells (Red) and bladder 5637 cells (Yellow) in 
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estimated copy numbers, with standard extraction protocol; (b) E.coli DH5a DNA yield 
in estimated copy numbers, with standard DNA extraction protocol, from mixture 
samples of E.coli DH5a cells or bladder 5637 cells; (c) DNA yield of E.coli DH5a cells 
(Red) and bladder 5637 cells (Yellow) in estimated copy numbers, with adapted 
extraction protocol; (d) E.coli DH5a DNA yield in estimated copy numbers, with adapted 
DNA extraction protocol, from mixture samples of E.coli DH5a cells or bladder 5637 
cells.  
 
Figure 3 Effect of host cells in the sample on microbial DNA yield. In this plot, pure 
cultures of E.coli DH5a cells or bladder 5637 cells (for a and c) or their mixtures (for b 
and d) at various amounts received DNA extraction with Qiagen QIAamp® DNA Stool 
Mini Kit standard protocol (for a and b) or adapted protocol, with the last collection steps 
involving the silicon-embedded filters were substituted by ethanol precipitation (for c and 
d). The x-axis shows sample cell number; Y-axis shows estimated DNA copy number 
after DNA extraction with qPCR (for E.coli DH5a cells) or DNA fluorometer and 
spectrophotometer (for bladder 5637 cells). (a) DNA yield of E.coli DH5a cells (Red) 
and bladder 5637 cells (Yellow) in estimated copy numbers, with standard extraction 
protocol; (b) E.coli DH5a DNA yield in estimated copy numbers, with standard DNA 
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extraction protocol, from mixture samples of E.coli DH5a cells or bladder 5637 cells; (c) 
DNA yield of E.coli DH5a cells (Red) and bladder 5637 cells (Yellow) in estimated copy 
numbers, with adapted extraction protocol; (d) E.coli DH5a DNA yield in estimated copy 
numbers, with adapted DNA extraction protocol, from mixture samples of E.coli DH5a 
cells or bladder 5637 cells.  
 
Figure 4 Effect of host DNA in the sample on microbial DNA yield. In this plot, E.coli 
DH5a DNA or bladder 5637 DNA samples (for a and c) or their mixtures (for b and d) at 
various copies where input into the DNA-binding column of MO BIO Powersoil® kit and 
went through its standard protocol (for a and b) or adapted protocol, with the last 
collection steps involving the silicon-embedded filters were substituted by ethanol 
precipitation (for c&d). X-axis shows sample cell number, Y-axis shows estimated DNA 
copy number after DNA extraction with qPCR (for E.coli DH5a cells) or DNA 
fluorometer and spectrophotometer (for bladder 5637 cells). (a) DNA yield of E.coli 
DH5a DNA (Red) and bladder 5637 DNA (Yellow) in estimated copy numbers, with 
standard extraction protocol; (b) E.coli DH5a DNA yield in estimated copy numbers, 
with standard DNA extraction protocol, from mixture samples of E.coli DH5a DNA or 
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bladder 5637 DNA; (c) DNA yield of E.coli DH5a DNA (Red) and bladder 5637 DNA 
(Yellow) in estimated copy numbers, with adapted extraction protocol; (d) E.coli DH5a 
DNA yield in estimated copy numbers, with adapted DNA extraction protocol, from 
mixture samples of E.coli DH5a DNA or bladder 5637 DNA.  
 
Figure 5 Effect of host DNA in the sample on microbial DNA yield. In this plot, E.coli 
DH5a DNA or bladder 5637 DNA samples (for a and c) or their mixtures (for b and d) at 
various copies where input into the DNA-binding column of Qiagen QIAamp® DNA 
Stool Mini Kit and went through its standard protocol (for a and b) or adapted protocol, 
with the last collection steps involving the silicon-embedded filters substituted by ethanol 
precipitation (for c&d). The x-axis shows sample cell number; Y-axis shows estimated 
DNA copy number after DNA extraction with qPCR (for E.coli DH5a cells) or DNA 
fluorometer and spectrophotometer (for bladder 5637 cells). (a) DNA yield of E.coli 
DH5a DNA (Red) and bladder 5637 DNA (Yellow) in estimated copy numbers, with 
standard extraction protocol; (b) E.coli DH5a DNA yield in estimated copy numbers, 
with standard DNA extraction protocol, from mixture samples of E.coli DH5a DNA or 
bladder 5637 DNA; (c) DNA yield of E.coli DH5a DNA (Red) and bladder 5637 DNA 
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(Yellow) in estimated copy numbers, with adapted extraction protocol; (d) E.coli DH5a 
DNA yield in estimated copy numbers, with adapted DNA extraction protocol, from 
mixture samples of E.coli DH5a DNA or bladder 5637 DNA. 
 
 
Figure 6 Effect of host DNA on 16s rRNA gene sequencing. Stacked bar plot showed 
percentage relative abundance of microbial species (n = 6) in even mock samples from 
16s rRNA gene sequencing. Each column stands for a mock sample. Mock samples are 
made with mixtures of six bacterial culture at even amount. Samples are sent in triplicates 
for sequencing. For each plot, the first column on the left demonstrates the composition 
of the input microbial mock sample. The next nine columns showed sequencing results of 
three sets of samples in triplicates, with each set of microbial mock sample spiked with 
no bladder 5637 cells, 103 5637 cells, 105 5637 cells respectively. Samples in this plot 
were DNA-extracted with MO BIO Powersoil® kit standard protocol (for d,e, and f ) or 
adapted protocol, with the final kit collection steps involving the silicon-embedded filters 
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were substituted by ethanol precipitation. (a) Mock samples with the estimated cell 
number of 109 and DNA-extracted with the adapted protocol. (b) Mock sample with the 
estimated cell number of 107 and DNA-extracted with the adapted protocol. (c) Mock 
sample with the estimated cell number of 105 and DNA-extracted with the adapted 
protocol. (d) Mock sample with the estimated cell number of 109 and DNA-extracted 
with the standard protocol. (e) Mock sample with the estimated cell number of 107 and 
DNA-extracted with the standard protocol. (f) Mock sample with the estimated cell 
number of 105 and DNA-extracted with the standard protocol.
Another issue associated with high host DNA abundance during PCR is the amplification 
of non-specific DNA by the 16S rRNA gene-targeted primers. Several primer sets based 
within conservative regions but designed to amplify adjacent V1-V3, V3-V4, V4 and V8-
V9 variable regions have been reported to non-specifically amplify human DNA. In our 
study, isolated gDNA of renal tissue samples was amplified with V4 primers, agarose gel 
electrophoresis of the amplification product demonstrated two bands at 385 kb and 302 
kb, which confirmed non-specific amplification (Figure 9a and 10). Non-specific 
amplification products can reach high abundance and potentially consume a significant 
proportion of a next generation sequencing run (Figure 9b). A commercial microbial 
DNA enrichment kit tested, was not able to fully mitigate the non-targeted amplification 
when human DNA was present in abundance (Figure 9c and 9d). In our experience, 
different primers have different amplification specificity on different samples types 
(Figure 11). Thus, a pilot study to test the amplification performance of a given primer-
sample combination maybe necessary before the main study starts. 
2.3.3 Investigating renal tumor tissue microbiota: simple protocol 
vs. refined protocol 
Using the refined protocol for human tissue microbiota investigation, we extracted and 
analyzed 56 renal cell carcinoma tissue samples and their adjacent pairs in non-tumour 
tissue. The mass and qPCR-estimated microbial abundance is presented in supplement 
file. DNA samples were PCR-amplified using the V4 16S rRNA gene region primers and 
sent for high throughput sequencing. An exploratory biplot (Figure 15a) shows that the 
“simple” protocol, as typically used for other microbiota studies (e.g., faecal material), 
utilizing column-based DNA extraction kits resembles that of the reagent control (no 
significant OTUs between the two group, using ALDEx2), suggesting sparse microbial 
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existence. However, when the samples were estimated of their microbial and host gDNA 
abundance with qPCR, DNA fluorometer and spectrophotometer, triaged according to 
their quality and processed through the refined algorithm, 
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Figure 7. Influence of non-target DNA upon the performance of PCR amplification and subsequent 
sequencing results. (a) Ct values of quantitative PCR to detect E.coli DH5a DNA were shown in the line 
plot. Mock samples were made of serially diluted E.coli DH5a DNA solution spiked with none, 103 copy 
and a 3.5x105 copy of bladder 5637 cell DNA. (b) Ct values of quantitative PCR to detect E.coli DH5a DNA 
were shown in the line plot. Mock samples were made of serially diluted bladder 5637 cell DNA solution 
spiked with 105 copy, 107copy and 109copy of E.coli DH5a DNA. Colored circles show changes of ct value 
of a 100-fold dilution 109 to 107 copy of E.coli DH5a DNA (red circles) or 107 to105 copy of E.coli DH5a 
DNA (blue circles). The inhibiting effect is alleviated after dilution. (c) Stacked bar plot showing results of 
percentage relative abundance of microbial species (n = 6) in even mock samples from 16s rRNA gene 
sequencing. Each column stands for a mock sample. Mock samples are made with mixtures of six bacterial 
culture with estimated 106 gDNA copy number. Samples are sent in triplicates for sequencing. The left most 
bars demonstrated the composition of the input microbial mock sample. The next three columns were 
sequencing results of reagent control. Each set of mock samples were spiked with bladder 5637 cell DNA at 
various concentration. (d) Compositional biplot of the same set of mock samples as described in (c). Sample 
sets were colored to make them distinguishable. The arrows indicate the amount and direction of variation of 
the ratio of each OTU to all others in the data set. The top and right axes indicate the values for variable 
loadings, and the bottom and left axes indicate the unit sum-of-squares values of the principle components. 
The proportion of variation explained by components 1 and 2 is also indicated. 
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Figure 8. Host depletion effects on human vaginal samples. Bar plot shows the 
proportion of sequencing reads of human origin. Four human vaginal swab samples went 
thorough this experiment. Samples labelled as “no depletion” are RNA samples in a 
transcriptomic experiment, while samples labelled as “depletion” are DNA samples in a 
metagenomic experiment, treated with NEBnext® Microbiome enrichment Kit. These 
data showed that microbial enrichment kit was unable to deplete the host component in a 
sample completely.
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Figure 9. Unspecific amplification of host DNA. (a) Agarose gel electrophoresis of PCR amplification products of a few renal 
samples. Besides the expected amplification product of V4 primers (385 bp, arrow) there is another band (302 bp, arrowhead), which 
were confirmed to be unspecific amplifications of human DNA (refer figure s5). (b) Dot plots showing the proportion of unspecific 
amplification for a batch of renal samples with low microbial abundance. Y-axis = mitochondrial% in sequencing results, x-axis = 
estimated human DNA% in samples as copy number achieved by qPCR, Nanodrop, and Qubit. For microbial qPCR, if microbial 
DNA below detection level then considers 100% human DNA. (c) and (d) Stacked bar plot showing proportion of unspecific host 
DNA amplification from V4 primer before (c) and after (d) treatment from a commercial microbial DNA enrichment kit. 
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Figure 10. BLAST alignment of V4 primer and human DNA sequences. 
 
Figure 11. Comparison of the primer combination. A batch of selected renal tissue 
samples was sent for sequencing with V4, V6 and V5V9 primers on separate sequencing 
run. Here’s a few of them for demonstration. Overall V4 primers had the highest 
amplification specificity.  
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Figure 12. Effects of PMA treatment on live and dead microbial cells and 
subsequent PCR amplification performance.  (a) PMA has little impact on qPCR 
quantification results of live E.coli DH5a cells, while it could deactivate the gDNA of 
heat-killed E.coli DH5a cells. Primer used: V6 (refer to Methods section) 
 
2.3.4 Refined processing for microbiota analysis of High-Low 
samples. 
To better handle the high-low samples, we developed a refined protocol including criteria 
to exclude the low-quality samples from sequencing (Figure 14b), and processing steps to 
mitigate the negative effect of host and background DNA, including surface washing, 
PMA treatment and microbial DNA enrichment (Figure 13). In the quality-checking 
experiment, the test samples were sent for 16S rRNA gene sequencing, and samples with 
contaminating bacterial reads lower than 1% is marked as “very good”, 1-10% as “good”, 
10-40% as “intermediate”, 40-60% as “poor” and higher than 60% as “very poor” (Figure 
14a). The estimated input cell number of G. vaginalis of these samples were recorded. 
After that, all samples sent for microbiota analysis will go through a quality-check 
algorithm to predict their risk of sequencing results (Figure 14). Samples with microbial 
abundance in “very poor” level were discarded, and the sequencing results of samples at 
“intermediate” and “poor” level would go through a self-developed, refined samples 
processing protocol to reduce the environmental and host DNA (Figure 12). For these 
samples, the proportion of host reads was taken into consideration, where in our practice 
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we set microbial reads under refined protocol > 80% as “low host proportion”, 40-80% as 
“intermediate host proportion” and <40% as “high host proportion”. In mock samples 
with G. vaginalis and bladder 5637 cells, we showed that the refined protocol could 
mitigate the adverse effect of background noise and non-target host DNA. (Figure 14c).A 
distinctive microbial consortium, different from the reagent and surface controls could be 
observed (Figure 15b). A different microbial pattern was identified between the tumour 
tissue group and normal adjacent tissue group, suggesting a potential different microbial 
community between these two sites. On samples processed following the kit 
manufacturer’s protocol, the separation was moderate, and no OTUs were detected as 
being significant by ALDEx2 test (Figure 15c). On the other hand, samples that went 
through the refined protocol demonstrated better separation, and 3 OTUs were detected 
as significantly different between the two sites (Figure 15d). Samples with intermediate 
to poor quality had better separation in the refined protocol. To confirm the sequencing 
result we also performed modified expanded quantitative urine culture (EQUC) of 
selected tissue samples and found that most taxonomies of the sequencing could be 
recovered from the culture, including Staphylococcus, Escherichia coli, 
Corynebacterium, Neisseria,Micrococcus, Sphingomonas, Weeksella, Alcaligenes, etc.. 
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Figure 13. Refined tissue sample processing algorithm for “High-low” samples 
Tissue samples 
Sample washing and surface control 
PMA treatment 
Amplification product purification 
Microbial DNA enrichment kit 
Ethanol precipitation-based DNA extraction 
Tissue homogenization 
Primer specificity test 
PCR amplification 
Agarose gel electrophoresis test for PCR product 
Gel extraction/ pippin-prep in case of unspecific amplification 
Expanded quantitative urine culture to confirm sequencing results 
16S gene amplicon sequencing 
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Figure 14. Developing a quality-checking algorithm for microbiota analysis of High-low samples. (a) 
Stacked bar plot demonstrating 16S rRNA gene sequencing result of serially diluted G. Vaginalis culture 
samples. Undiluted culture has about 108 cells. Each column represents a sample. As input cell number 
decreases, the proportion of non-target, “noise” sequencing reads increases. Sample quality was determined 
by the proportion of “noise” reads. (b) The processing algorithm for microbiota analysis of High-Low 
samples. Samples with high microbial abundance usually yield decent sequencing results, and samples with 
very low microbial abundance should be discarded. Samples with intermediate microbial and host DNA 
proportion should go through further processing to aaaaaaaoptimise the sequencing results. (c) 16S rRNA 
gene sequencing result of samples consisted of 106 cells of G. Vaginalis culture mixed with a various 
amount of bladder 5637 cells. Triplicates were taken for each sample to go through PCR and 16S rRNA 
sequencing. For one set of samples both routine sample processing protocols and refined sample processing 
protocols were utilized and the sequencing results were compared. 
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Figure 15. Compositional biplot of the renal tissue sample microbiota.  
Samples were coloured to demonstrate their quality. The arrows indicate the amount and 
direction of variation of the ratio of each OTU to all others in the data set. The top and 
right axes indicate the values for variable loadings, and the bottom and left axes indicate 
the unit sum-of-squares values of the principle components. The proportion of variation 
explained by components 1 and two is also indicated. (a) Biplot of all samples. (b). Biplot 
of all samples but coloured differently. Here the surface control samples were in red, 
renal tissue samples that went through the refined protocol were in blue, while samples 
that went through simple protocol were in green.  (c) Biplot the paired renal tumour tissue 
vs normal adjacent tissue samples that were processed under the simple protocol. (d) 
Biplot of the paired renal tumour tissue vs normal adjacent tissue samples that were 
processed under the refined protocol. 
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2.4 Discussion 
The 16S rRNA gene sequencing based microbial identification is one of the most 
widely used methods to study human microbiota. Thanks to its culture-independent 
nature, numerous previously undescribed bacterial types were found inhabiting a 
human body (Lau et al., 2004; Woo et al., 2005). However, 16S rRNA gene 
sequencing-based methods also have drawbacks, including multiplex-associated 
biases, limited resolution at the certain species level, inability to differentiate between 
bacterial DNA and viable bacterial cells (Janda & Abbott, 2007). In this study, we 
showed that conventional sample processing methods derived from gut microbiota 
studies were not optimal for handling low microbial, high host abundance DNA 
samples. We then developed a refined protocol specifically for these sample types. 
Finally, utilising this protocol, we looked at the microbial consortia from renal 
carcinoma tissue and their normal adjacent counterparts.  
Our results demonstrated that samples with high host eukaryotic DNA abundance and 
low microbial biomass (“high-low” samples) would compromise the sequencing 
results in multiple levels: firstly, the eukaryotic and prokaryotic DNA compete in 
binding to the silicone filter in the DNA extraction columns typically used in 
extraction kits, leading to a compromised prokaryotic DNA yield due to lack of 
capacity, as is shown in Figure 2b in comparison to 2d. In our experiment, this 
phenomenon was observed when both cells or free DNA was transferred into the DNA 
extraction column, suggesting that it is eukaryotic DNA, not cellular components, that 
compromised microbial DNA yield. Since the estimation of isolated microbial gDNA 
copy number was performed with qPCR, we also used microbial DNA enrichment kit 
(New England Biolabs) to deplete human DNA, and received similar results (data not 
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shown) This suggests the effect is not caused by inhibitive effect of human DNA 
during qPCR. In fact, commercially available DNA extraction kits can handle 
common samples without issues. Taking Qiagen QIAamp® and MOBIO Powersoil®, 
two of the most commonly used DNA extraction kit for gut microbiota studies for 
example, the QIAamp® column has a binding capability of up to 4-12 ug per filter, 
while the Powersoil® column has a binding capability of 20 ug per filter, as stated in 
their user manuals. Given that most gut microbes have a genome size around 4-6 Mb, 
this binding capability could retrieve presumably as high as 109 copies of bacterial 
gDNA, which will indubitably have a decent representation of gut microbial 
communities. However, when it comes to high-low samples, given eukaryotic cells’ 
much higher genome size (3000 Mb homo sapiean genome), a DNA collection filter 
could only hold around 6.5x106 cells in theory. This calculation matches our results 
that the bladder 5637 gDNA yield reaches a plateau at around 106 copies (Figure 2a). 
Since one gram of solid tumour is estimated to have 108 to 109 tumour cells (Del 
Monte et al., 2009; Rasnick et al., 2002) a common input of 200 ug tissue sample 
could contain 2x107 to 2x108 cells, which could easily saturate the DNA extraction 
columns. Given this and the low prokaryotic/eukaryotic gDNA ratio, the prokaryotic 
DNA yield could be very low in these columns and bear the risk of poor representation 
of the sample microbial community. To our knowledge, this column-associated risk 
factor is not recognised in tissue microbiota studies. 
Secondly, high eukaryotic DNA concentration could also affect PCR-
amplification of microbial DNA. In our qPCR quantification experiment, the Ct 
value of 109 copies of E.coli gDNA increased from 9.4 to 18.97 with the presence of 
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3.5x105 copies of bladder 5637 gDNA (Figure 7a). Although appropriate dilution of 
samples mitigated the inhibitive effect (Figure 7b), when microbial biomass dropped 
below 104 the sequencing result was severely biased by reagent and background DNA, 
as we shown later in Figure 14a. Therefore, it is crucial to understand which sample 
can have a better sequencing quality with dilution. Our quality-checking algorithm in 
Figure 14b helped to solve this issue.  
Thirdly, high host DNA abundance leads to unspecific amplification of commonly 
used primers, consuming sequencing depths. Host DNA consuming sequencing depth 
is a known issue in whole genome sequencing and RNA sequencing (Feehery et al., 
2013). Studies with whole genome shotgun sequencing in the presence of large amounts 
of host eukaryotic DNA have shown that the background DNA will consume significant 
amounts of sequencing depth, making sequencing inefficient, time-consuming and 
inaccurate (Feehery et al., 2013). In our study, it appears that the sequencing depth of 
16S rRNA gene sequencing the presence of a high predominance of host DNA is also 
compromised, due to unspecific amplification of 16s rRNA gene primers. This 
phenomenon was previously reported in microbiota study of blood samples and heart 
valve samples (Kühn et al., 2011; Rogina et al., 2014), but to our knowledge, there’s no 
report that this unspecific amplification consumes a remarkable number of reads in 16s 
rRNA gene sequencing of high-low samples. Based on our results, we recommend testing 
primer combinations for lowest unspecific amplification, using microbial enrichment kits 
to deplete human DNA, and perform amplification product purification by agarose gel 
cutting and extraction for the sample with very high host DNA abundance. 
Based on these results, we then proposed that a refined protocol should be utilised when 
processing high-low samples. To avoid filter competition issue, we used ethanol 
precipitation as an alternative to column-binding systems to recover sample DNA and 
showed that it effectively recovers DNA without reaching a “capacity ceiling”, and it did 
increase microbial DNA yield in mock samples (Figure 2c and 2d). We also utilised 
microbial enrichment kit to deplete eukaryotic DNA. As shown in our study, the 
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enrichment kit alone is insufficient to deplete host DNA completely (Figure 8), but it did 
exert positive effect when incorporated in the refined protocol (Figure 15). 
In this protocol, besides issues associated with host DNA, we also seek to solve issues of 
samples with low microbial biomass by identifying the lower limit of sample microbial 
gDNA concentration level below which the 16S rRNA gene sequencing results will lose 
its fidelity and value. We used a Gardnerella vaginalis strain to perform this quality-
checking experiment because it is commonly associated with the urinary tract and has not 
been reported as a contaminant in DNA extraction kits or other reagents. In our study, 
samples with a microbial abundance lower than 104/ml had >60% contamination reads 
and were discarded, while samples with 10-60% contamination reads went through the 
refined protocol for optimised sequencing quality. Since different labs have varying risks 
to contamination due to their environment and reagent usage, an individualised lower 
limit determination should be performed for each lab at least once before 16S rRNA gene 
sequencing, though such quality assurance checks don’t appear to be described in the 
literature.  
With our developed protocol, we examined renal tumour and healthy adjacent tissue from 
the same individuals for the presence of microbiota. Again, the refined protocol produced 
better sequencing quality, as better separation of tissue samples from reagent controls 
were observed. Many of the microbial species in the sequencing results were confirmed 
by enhanced culture results, suggesting exitance of viable microbes in renal tissues. 
Admittedly, conditions such as pyelonephritis typically occur where obstruction can be 
present in the urogenital tract. This infection can be the result of urolithiasis and tumour. 
The former has been reported in early investigations of the bacterial composition of 
pediatric kidney stones which appear to show the presence of E. coli (Barr-Beare et al., 
2015). 
The limitation of this study includes: the refined protocol embeds several self-developed 
steps including ethanol precipitation, sample surface washing and PMA treatment etc. 
since no specialised regent or materials are commercially available. These steps bear 
risks of introducing contamination or decreased microbial DNA yield when not 
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appropriately handled. On the other hand, culture and sequencing-based techniques are 
unable to provide direct visual evidence of bacteria in renal tissue, and therefore unable 
to exclude the possibility of microbial contamination during renal tissue collection, 
storage and handling.  
In summary, host DNA and reagent/environmental DNA have a negative effect on 
sequencing qualities of high-low samples. Our self-developed refined protocol could 
mitigate some of these effects and revealed microbiota profiles in renal tissue samples.
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Chapter 3  
3 Exploration and comparison of the urinary microbiota of 
healthy individuals and urinary stone patients. 
3.1 Introduction 
Few clinical practitioners believe that the urinary tract of a healthy individual harbours a 
community of viable microorganisms. The dogma during medical education is that the 
presence of bacteria in urine correlates with pathological conditions such as 
asymptomatic bacteriuria or urinary tract infections (UTI). The definition of these 
conditions are based on one paradigm: that is urine in healthy individuals is “sterile” and 
when the numbers of bacteria caught from a urine sample exceeds a given threshold 
(usually 105 colony-forming units [CFU] per ml), a determination of a “positive culture 
result” is made, and the patient is considered as having a pathological condition. 
However, microbiologists are becoming gradually aware that traditional culture methods 
favour fast-growing microbial species and ignore the slower-growing, more fastidious 
commensal organisms (Pace et al., 1997). The later discoveries of intracellular bacteria in 
urothelial cells and biofilms formation in urinary tract showed evidence of bacteria in 
urine culture-negative individuals, and further weakened the solidity of the paradigm 
(Hancock et al., 2007; Salo et al., 2009). Since the appearance of culture-independent, 
sequencing-based microbial analysing methods over the past two decades from 
denaturing gradient gel electrophoresis to next-generation sequencing analysis, multiple 
studies have reported evidence of microorganisms in the urinary tract (Burton et al., 
2011).  
Compared to other human sites occupied by bacteria, the urinary tract does not harbour 
the richest habitat for microbes in the human body, which is partly the reason why it may 
not have been included as a site examined in the original human microbiome project 
(Consortium et al., 2012). We have shown in the previous chapter, that samples with low 
microbial mass are more vulnerable to bias. This may be one of the reasons why previous 
studies of urinary tract microbiota all have discrepancies between their reported urinary 
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microbial community compositions. Additionally, there are no optimal sample storage 
and processing methods for urine samples yet described in the literature.  
Many links are now emerging between the microbiota and numerous conditions, not just 
those associated with the gut microbiota and the urinary microbiota should not be 
overlooked either. For example, urinary stones are among the most common urological 
conditions, with 16% of the male and 8% of the female population developing at least 
one symptomatic stone episode in their lifespan (Scales et al., 2012). Previously, 
urologists only thought that bacteria only played a role in the formation of a certain 
specified type of urinary stones, namely struvite stones, but in fact, reports have shown 
that bacteria could be found in most commonly seen calcium oxalate stones (Bratell et al. 
1990; Dewan et al., 1997; Gault et al., 1995; Hugosson et al. 1990; Larsen et al., 1986; 
Lewi et al., 1984; McCartney et al., 1985). At present, a systemic description of urinary 
microbiota patterns among urinary stone patients is still lacking. Such a description could 
provide useful mechanistic and potentially diagnostic information. 
In this chapter, I detail how I have optimised the methodology for urine sample 
collection, storage and processing, and microbiota analysis. Then using these 
methodologies, I undertook an analysis of the urinary microbiota of urinary stone 
patients, comparing it to a group of age-matched, healthy individuals. I further explored 
the longitudinal stability of the urinary microbiota of individuals in these two groups. 
3.2 Methods 
3.2.1 Evaluation of optimal storage of urine for microbiota analysis 
It is well documented that the storage and handling of samples for 16S rRNA gene and 
other types of NGS analysis should be undertaken in a standard manner (Di Bella et al., 
2013). Ideally, the extraction, sequencing and analysis should be done simultaneously 
and therefore, the optimisation of the storage of clinical samples until this can occur is 
important (Bao et al., 2017).  
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To determine the optimal volume and processing for the storage of urine for microbiota 
analysis, urine samples from four healthy donors were collected. The demographic 
information of these four donors is shown in table 5. 
Table 5. Demographic information of healthy donors for storage methods 
optimization 
Donor Gender Age Active UTI 
1 Male 28 No 
2 Female 23 No 
3 Female 68 No 
4 Male 26 No 
 
Urine sample collection methods are the same as the clinical urine sample collection 
methods, described below in the “Sample collection” section. Each donor provided 
multiple urine samples that were first pooled together then distributed into multiple forms 
as described in table 6. Samples in groups A and C were centrifuged at 1000 x g for 10 
minutes. The supernatant was discarded, and the pellets were stored at -80 ℃. In groups 
B and D, whole urine of the desired volume was transferred to a sterile urine sample 
container (Starplex, VWR) then stored in -80 ℃.  
3.2.2 Clinical study design and study population 
All specimens used in this study were collected, following a protocol approved by the 
appropriate human ethics boards at Western University, Canada and West China 
Hospital, Sichuan University, China. The participants in the stone group were patients 
admitted to St. Joseph Hospital, London, ON, Canada and West China Hospital, Sichuan 
University, China. Inclusion criteria were participants at least 18 years of age, non-
pregnant, with no other infectious conditions, not receiving antibiotics or chemotherapy. 
92 
 
 
The diagnosis of urinary stone was confirmed with radiological investigation, and the 
patient would be scheduled to receive surgical intervention (either extracorporeal shock 
wave lithotripsy (ESWL), percutaneous nephrolithotomy (PCNL) or ureteroscopy) at St. 
Joseph’s Hospital. Patients were sub-grouped depending on their gender, age and location 
of the stones, type of surgery they receive, chemical composition of the stone and 
whether a ureteral stent is inserted. After informed consent, participants were asked to 
provide two urine samples: one at the patient’s clinic visit for preoperative evaluation, 
and one at the patients visit for post-operative follow up. For healthy volunteers, two 
urine samples were collected with a gap of three months. All patient information was 
blinded until all sample processing and DNA sequencing work were completed and only 
then would the patients identified by their name initials to retrieve their grouping and 
demographic information for statistical analysis.  
Table 6. Urine sample collected for storage methods optimization 
Groups Volume Forms Storage period 
A 
2ml 
10ml 
20ml 
50ml 
100ml 
Pellets 1 Month 
B 
2ml 
10ml 
20ml 
50ml 
100ml 
Whole urine 1 Month 
C 20ml Pellets 
1 Month 
6 Months 
1 Year 
2 Years 
D 20ml Whole Urine 
1 Month 
6 Months 
1 Year 
2 Years 
Control 2ml Reagents 
1 Month 
6 Month 
1 Year 
2 Years 
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3.2.3 Sample collection 
All participants were instructed to wash their hands thoroughly with soap and water, then 
to clean and wash their external genitalia with an antiseptic towelette. Urine samples 
were taken with a clean-catch, midstream voided fashion: the first 10 mL was discarded, 
the majority of the voided volume collected in a sterile container, and the final voided 
volume was dispensed into the toilet. Once collected, all urine samples were processed 
within one hour. Microbiological cultures were performed subsequently, and the 
remaining of urine samples were spun down to pellets and stored at -80 ℃. 
3.2.4 Microbiological culture 
All collected samples were quantitatively cultured on Colombia Blood Agar with 5% 
sheep blood, LB agar and MacConkey agar. Urine samples with a CFU > 105 per mL 
were to be considered as active UTI and excluded. All cultivated strains were isolated 
and stored. Enhanced quantitative urine culture (EQUC) was also applied following 
protocols developed by Hilt et al. (Hilt et al., 2014). In brief, urine samples were cultured 
with higher volume input (100ul and up to 1ml), enriched culture media (CBA, CAN 
agars and thioglycolate medium), both aerobic and anaerobic culture atmosphere and 
extended culture time (up to 5 days). For each morphologically unique colony on the 
plate it was re-streaked into a new plate for taxonomy identification. The culture of 
Ureaplasma species was following the clinical laboratory protocol adapted from ATCC 
2616 Medium: basal medium [3.5 g PPLO broth, 10 g pancreatic digest of casein 
(tryptone), 5 g pancreatic digest of gelatine (peptone) and 500 ml distilled water, 
followed by aseptic addition of filtered sterilised solutions [50 ml 10X CMRL 1066 
medium, 35 ml yeast extract solution, 20 ml yeastolate (10% w/v), 170 ml foetal bovine 
serum, 20 ml 0.1% phenol red solution, 1 g urea and 205 ml distilled water. 
3.2.5 DNA isolation 
After storing, the samples were thawed on ice. DNA extraction was performed with 
MOBIO PowerSoil® 96 well kit. In brief, lysis buffer and beads were added to urine or 
urine pellets. Lysis of cells was achieved with mechanical and chemical methods. The 
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suspension was then transferred to a new tube, and the subsequent procedure was 
following manufacturer’s instructions.  
3.2.6 16S rRNA gene library generation and sequencing 
Extracted DNA from the clinical samples were PCR-amplified with barcoded primers as 
described by Gloor et al. (2010) shown in Appendix A. The PCR was performed in a 42-
μl reaction system, with details listed in Appendix B. Following PCR, the amplicons 
were quantified with the Qubit 2.0 fluorometer (Invitrogen, CA, USA). Equimolar 
amounts of each amplicon were aliquoted into a single tube purified with the QIAquick 
purification kit (Qiagen, Mississauga, ON, Canada). Each product was then pooled and 
sequenced on the Illumina Mi-Seq platform in a paired-end run using a 600 cycle kit with 
a paired-end 220-bp run at the London Regional Genomics Center (Robarts Research 
Institute, London, ON, Canada), following standard operating procedures. 
3.2.7  Sequencing reads processing and taxonomic assignment. 
Description of the processing algorithm has been previously published (Gloor et al., 
2010). The SOP and related software are accessible at 
http://github.com/ggloor/miseq_bin. The sequences were processed following algorithm 
as stated in Appendix C. Paired-end reads were overlapped with Pandaseq V2.5 (Masella 
et al., 2012), allowing no ambiguous positions in the overlapped reads. Reads were then 
demultiplexed and tagged with the name corresponding to the sample identifier and 
barcode. After demultiplexing, reads from all samples were merged into one single file 
and were clustered into individual sequence units (ISUs), which were then further 
grouped into operational taxonomic units (OTUs) with open reference OTU picking 
method, using Uclust algorithm of USEARCH version 7, which has a de novo chimera 
filtering step built into it (Edgar et al., 2010; Edgar et al., 2015). The identity threshold 
was 97%. Singleton OTUs and ones with abundance < 1% were discarded. Taxonomical 
assignment was performed with mothur 1.3.4 to annotate the OTU sequences against the 
Silva database (v119). 
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3.2.8 Bioinformatic analysis 
For data exploration, OTUs with a zero value was replaced by a small numerical value 
with the count zero multiplicative methods in the zCompositions package (Palarea-
Albaladejo et al., 2015). Custom R codes were generated to perform centred log ratio 
(clr) transform of the zero-replaced data set. Then a singular value decomposition (SVD) 
was applied to the data. The output was used for PCA plots exploration. 128 Dirichlet 
Monte-Carlo (DMC) instances from the data with clr-transform were used for 
quantitative data analysis. ALDEx 2 V.1.6.0 package were used for differential 
abundance test. Significance was based on the Benjamini-Hochberg corrected P value of 
the Wilcoxon rank test (significance threshold P < 0.1). 
3.2.9 qPCR estimation of 16S rRNA gene copy numbers. 
The bacterial load in the urine samples were estimated by qPCR quantification of the 
DNA extracts. The reaction system includes 10ul of PCR master mix, 5 ul of 800Nm 
primer stock (V6 hypervariable region of 16S rRNA gene: V6-LT 5’ - 
CCATCTCATCCCTGCGTGTCTCCGACTCAGNNNNNCWACGCGARGAACCTTA
CC3’ 
and V6-RT: 5’CCTCTCTATGGGCAGTCGGTGATACRACACGAGCTGACGAC 3’), 
5ul of sample DNA template. A standard curve was made with known copies of E.coli 
DH5a gDNA. 
3.3 Results 
3.3.1 Methods optimization for sample storage 
We first investigated how urine samples storage/preserving techniques could affect their 
sequencing qualities. Urine samples from healthy donors were either kept in pellets 
(Group A) or as whole urine (Group B) for one month and then PCR-amplified with V4 
primer and sent for sequencing. Among all group A samples, the ones stored at a higher 
volume had greater weighted UniFrac distances to reagents, suggesting it provided a 
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representation of the urinary microbiota (Figure 16). Figure 17 presents urine samples 
from one donor that were either stored as whole urine or in pellets. As shown in the 
PCOA plot, urine pellets had better separation from the reagents, suggesting a better 
representation of the urinary microbiota. Urine samples with higher volumes generally 
had better representation. Pooling the UniFrac distances to reagents of samples from all 
four donors, in all volume levels the pelletted urine samples had higher weighted UniFrac 
distances to reagents than whole urine samples. For pelleted urine samples, the weighted 
UniFrac distances to reagents tended to stabilize after urine samples have a volume 
higher than 20 ml, while for whole urine samples it seemed to need more than 100ml to 
reach a decent weighted UniFrac distance to reagents (Figure 18). These results showed 
that urine stored in pellets might have a better representation of the urinary microbiota of 
the donor. Samples pelleted from a urine sample with a volume higher than 20 ml seemed 
to have better representation. 
 
Figure 16. PCOA plot showing weighted UniFrac distances of urine samples stored 
in pellets (Group A) with various volume and reagent controls. The volume of each 
sample is marked in the figure. For better representation only one sample of each 
volume from one donor. 
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Figure 17. PCOA plot showing weighted UniFrac distances of pelleted urine samples 
(Group A, blue) and whole urine samples (Group B, green) and reagents. The 
volume of each sample is marked in the figure. For better representation, only one 
sample of each volume from one donor is shown here. 
 
Figure 18. UniFrac distances of samples from all four donors, both in pellets and 
whole urine (Group A & B), to reagents. 
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We then proceeded to explore if storage time could affect sequencing results. Both urine 
pellets (Group C) and whole urine (Group D) were stored in -80℃ for one month, six 
months, 1 and two years before they were processed and sent for sequencing. Group C 
samples demonstrated a relatively consistent UniFrac distances to reagent through 
various time points, while Group D samples showed a more obvious decrease over time 
(Figure 18 and Figure 19). When compared to samples that only stored in one month, 
Group D samples over time showed a more remarkable increase in weighted UniFrac 
distances while Group C sample maintained stable (Figure 19). These results showed that 
stored sample over time would decrease in quality, but samples kept in pellets would 
mitigate these effects. 
 
Figure 19. PCOA plot showing weighted UniFrac distances of pelleted urine samples 
(Group C, blue) and whole urine samples (Group D, red) and reagents. The storage 
time of each sample is marked in the plot. For better representation, only one 
sample of each volume from one donor is shown here. 
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Figure 20. UniFrac distances of samples from all four donors, both in pellets and 
whole urine (Group C & D), to reagents. The black dots showed UniFrac distances of 
samples over time to samples stored in one month. 
3.3.2 Microbiota pattern of urinary stone patients 
3.3.2.1 Characterization of the urinary microbiota of healthy 
subjects and stone patients. 
A total of 116 urine samples were collected. The demographic information of all donors 
is presented in Table 7. We characterised the microbial composition of urine samples 
from 41 from healthy individuals (22 female and 19 male) and 61 from stone patients (31 
female and 30 male), after excluding samples with bacterial growth exceeding 105 
CFU/mL and samples with low sequencing reads. Four hundred and fourteen bacterial 
operational taxonomic units (OTUs) in total were identified in the sequencing result. On 
average, one sample contained 5338 reads.   
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The urinary microbiota patterns of women had higher alpha diversity compared to men, 
although there was no statistical significance (Figure 21). An exploratory compositional 
biplot of the samples from healthy male and female donors showed that 21.4% and 
11.8%, respectively, of the variation could be explained by the first and second 
components, and was likely due to the relative abundance of Lactobacillus, 
Corynebacterium and Staphylococcus species. The urinary microbiota of the two genders 
demonstrated distinct patterns: urine samples from a male donor were most commonly 
predominated by a single genus, usually Corynebacterium, Staphylococcus and 
Streptococcus, and occasionally by Lactobacillus, Enterobacteriaceae species 
(presumably Escherichia coli), Anaerococcus, Gardnerella and Prevotella. Urine 
samples from a female donor, on the other hands, consisted of a more heterogeneous 
microbial community, usually predominated by Lactobacillus species (Figure 22). When 
comparing the urinary microbiota of healthy male and female, it was noted that female 
urinary microbiota contained higher proportions of Lactobacillus species, while male 
urinary microbiota contained higher proportions of Corynebacterium or Staphylococcus 
species (Figure 23-28). qPCR quantification of 16S rRNA gene operon copy numbers 
showed that a voided urine sample from a female donor has slightly higher copy number 
of rRNA operons than her male counterpart, both healthy subjects and stone patients, but 
without statistical significance (Figure 29)   
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Table 7. Demographic information of the urinary microbiota study participants (3). 
 Urinary stone patients Healthy volunteers 
Female (n, %) 31 50.8 22 53.7 
Age (n, %)     
20-29 3 4.9 2 4.9 
30-39 6 9.8 8 19.5 
40-49 16 26.2 8 19.5 
50-59 20 32.8 13 31.7 
60-69 13 21.3 5 14.6  
70-79 3 4.9 5 9.7 
Median 51 -   
Operation (n, %)     
SWL 17 27.9 - - 
URS 37 60.7 - - 
PCNL 7 11.2 - - 
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Figure 21. Relative abundance taxa bar blot of urine samples from healthy 
individuals and stone patients. Taxa (groups of 16s rRNA gene sequences) are 
represented at the genus level. The dendrogram represents the hierarchical average-
linkage clustering of the microbiota profiles based on the computed weighted UniFrac 
distances. 
103 
 
 
 
 
Figure 22. Distribution of alpha diversity within groups as measured by Shannon 
index. The left two boxes represent the calculated Shannon index for urine 
microbiota samples from healthy male and female donors while the right two boxes 
were samples from male and female patients of urinary stones.  
 
S
h
a
n
n
o
n
's
 d
iv
e
rs
it
y
 i
n
d
e
x
M
a
le
 H
e
a
lt
h
y
F
e
m
a
le
 H
e
a
lh
ty
M
a
le
 S
to
n
e
F
e
m
a
le
 S
to
n
e
0
1
2
3
4
5
104 
 
 
 
 
Figure 23. Compositional biplot of urinary microbiota of healthy male donors (blue) 
and healthy female donors (red) 
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Figure 24. Box plot of the difference in bacterial abundance between healthy male 
and female. Taxa with high effect sizes are shown. The bacterial abundances were 
presented in relative abundance as computed by ALDEx2.  
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When comparing the urinary microbiota between the healthy individuals and the stone 
patients, a trend of separation could be observed in both male and female groups on 
biplot, but there was no clear separation (Figure 25 and 27). Male stone patients had 
slightly higher relative abundances in Escherichia and Fingoldia species comparing to 
healthy donors, while female stone patients had slightly higher relative abundances in 
Prevotella, Streptococcus, Finegoldia and Peptoniphilus species, although none of these 
differences reached statistical significance (Figure 26 and 28). The analysis based on 
weighted UniFrac did not observe a clear clustering of healthy or stone samples at the 
genus level (Figure 31). Similarly, no differences in alpha and beta diversity were 
observed among the level of stone size, location and composition (data not shown). In 
summary, no taxa were found significantly different between stone patient and healthy 
individual in both genders in this study. 
3.3.2.2 Longitudinal stability of urinary microbiota  
The aim was to investigate how the urinary microbiota changed throughout time. Two 
samples were collected from each person with approximately three months between 
collections (refers to the demographic table). Of all included participants, 70 had their 
follow-up sample collected (18/19 healthy male, 19/22 healthy female, 17/30 male stone, 
16/31 female stone). 
The UniFrac phylogenetic distance metric was calculated to measure the distance of the 
samples from one donor of two time points to samples from one donor to another donor. 
The UniFrac score ranges from 0 to 1. A lower UniFrac score means higher similarity of 
the microbiota between the compared samples to samples with higher UniFrac scores. If 
the UniFrac score was 0, it means the microbiota profiles of the two samples were exactly 
the same. If the UniFrac score was 1, it suggests two completely microbiota profiles with 
no overlapping species. Figure 30 demonstrated the UniFrac distances of samples from 
one donor and samples from different donors. Across all conditions (male 
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Figure 25. Compositional biplot of urinary microbiota of healthy male donors (blue) 
and male stone patients (red) 
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Figure 26. Box plot of the difference in bacterial abundance between healthy male 
individuals and male urine stone patients. Taxa with high effect sizes are shown. 
The bacterial abundances were presented in relative abundance as computed by 
ALDEx2. 
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Figure 27. Compositional biplot of urinary microbiota of healthy male donors (blue) 
and male stone patients (red) 
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Figure 28. Box plot of the difference in bacterial abundance between healthy female 
individuals and female urine stone patients. Taxa with high effect sizes are shown. 
The bacterial abundances were presented in relative abundance as computed by 
ALDEx2.  
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Figure 29. qPCR estimation of bacterial load in urine pellet samples. The result was 
reported as the estimated number of operon copies of 16S rRNA present per urine 
pellet. 
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Figure 30. Weighted UniFrac distance between samples from one donor (black dots) 
and between samples of different donors (white squares). For clearer presentation, 
each white square represents the mean weighted UniFrac distance of the first 
sample from one donor to the samples of all other donors.  
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or female, stone or healthy), samples from one donor collected from two time points had 
significantly lower UniFrac scores than samples from different donors, which suggested 
the variation of the urinary microbiota of one individual is always smaller than the 
difference of urinary microbiota profiles of two individuals. These results suggested that 
the urinary microbiota of one individual stays relatively stable throughout time. 
 
3.3.2.3 Mutual support culture-based methods and 16S rRNA 
sequencing in microbial detection 
Among all 116 urine samples collected, 14 had higher than 105 CFU/mL, and the 
participants were excluded. Of the remaining 102 samples, 76 had positive cultures. 
Among them, 43 samples were negative for traditional culture but had positive EQUC 
culture results. Almost all cultured species had corresponding OTUs in the sequencing 
results, and usually, they were the most predominant or second predominant genus in the 
sample. Also, there were two cases of interest: in one sample, a colony was retrieved, and 
Sanger sequencing confirmed it to be Weeksella virosa. Interestingly, the 16S rDNA 
sequencing result of this sample the reads of the OTU attributed to Weeksella only 
accounted for only 1.32% of the total reads, while Weeksella virosa is the only microbial 
species that was retrieved by culture-based methods. On the other hand, in another 
sample, 32.32% of reads were unusually attributed to Ureaplasma species, while routine 
culture methods failed to grow any Ureaplasma. However, when Ureaplasma-specific 
media and atmosphere (refer to methods section) were utilized, it was possible to culture 
Ureaplasma ureealyticum.  These results showed that the combination of culture-based 
techniques and sequencing-based techniques could yield the highest sensitivity and 
accuracy in microbial detection in clinical samples.  
 
3.4 Discussion  
In this study, we first sought to optimise the methodology for urine sample storage to 
obtain the highest fidelity in 16S rRNA gene sequencing; then we explored the urinary 
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microbiota profiles of healthy individuals with culture-based and sequencing-based 
techniques. The urinary microbiota of an individual maintained its profile features 
throughout the multiple sampling points, making it distinct from the urinary microbiota 
from other individuals.  
The value of proper sample collection and handling methods can never be under-
emphasised in microbiota studies. Each sample type has its unique features that must be 
taken into account for sample acquisition and processing. Common sample type for 
human microbiota studies such as stool, saliva and vaginal fluids have well-established 
handling methods (Abrahamson et al., 2015; Goodrich et al., 2014; Kumar et al., 2014; 
Ott et al., 2004). However, no consensus has yet been reached on the optimal protocol for 
urine sample collection and storage. Unlike stool or saliva, urine samples have their own 
features relating to how they perform when processed for microbiota analysis: (a) Low 
microbial biomass in urine sample means it tends to be affected by reagent and 
environmental contamination (see chapter two) and (b) The liquid form of a urine sample 
makes it more susceptible to the freeze-thaw process, as explained below. 
Since the microbial biomass in a urine sample from a healthy subject is low, a relatively 
large amount of urine is required to have a decent representation of the urinary 
microbiota. In this study, as the volume of the urine sample increased, a higher UniFrac 
distance score was achieved to reagent controls, suggesting a better representation of the 
original urinary microbiota. The UniFrac score was also noted to reach its “plateau 
phase” after volume reaches 20 mL, suggesting that this volume may be the minimal 
appropriate for urinary microbiota sampling. Several previously published studies 
investigating urinary microbiota would use a low urine volume such as 1 ml, 2 ml or 10 
ml (Lewis et al., 2013; Nelson et al., 2010; Pearce et al., 2014). Their sequencing quality 
may, therefore, be compromised.  
Since the DNA extraction of urine samples includes a step of centrifuging the urine 
sample and discarding the supernatant, all DNA released into that urine would be lost. 
The freeze-thaw process may lead to microbial cellular rupture, releasing their DNA into 
the urine and loss following centrifugation. Common cryoprotectants in traditional 
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microbiology experiments such as glycerol do not have a DNA-free form that is 
compatible with microbiota investigation. Therefore, when the whole urine is frozen in -
70℃ without any cryoprotectants, its quality will have a remarkable drop. Keeping urine 
in pellets avoids discarding the supernatant, thus transferring all microbial components 
into the DNA extraction experiment.  
To my knowledge, this is the first report of the optimal storage form of urine samples. As 
the technical progress of high-throughput sequencing, many study groups and 
commercial companies are planning on sequencing-based studies of urine samples. 
Therefore, developing a standard protocol for sample handling and storage is crucial. The 
data generated here may provide some reference. 
The present study observed different urinary microbiota features between male and 
females but did not identify a “stone-related” microbiota, as no clear distinction from 
healthy individual and stone patients of the same gender could be found. One possibility 
is that there’s no such “stone-related” microbiota, especially in patients with no acute 
infective episodes. Another possibility is the inclusion criteria did not specify frequently 
recurrent stone patients, or patients with a specific stone composition, which may be 
more likely to have a specific urinary microbiota (Maalouf et al., 2012). Alternatively, 
the impedance of urine through one ureter may not be detected by used here, or if only 
small numbers of bacteria are released this may also be below the levels of detection. 
Barr-Beare et al. explored the stone microbiota with both sequencing-based methods and 
EQUC and found several known uropathogens including E.coli, Pseudomonas, 
Gardnerella et al. in the stone (Barr-Beare et al., 2015), which suggests microbes do 
inhabit non-infectious, calcium-based stones. However, other studies also report that 
urine samples have lower sensitivity to detect stone-harboured microbes compared to 
stone samples,  which may explain the inability to identify a stone-specific microbiota in 
the urine samples tested here. 
The urinary microbiota was found to have its longitudinal stability throughout three 
months. Urine samples from one individual in different time points were always more 
similar than samples from different individuals. This phenomenon persisted in both 
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genders, and in both healthy, and stone donors. It is also worth noting that the urinary 
microbiota maintained its stability in stone patients, even after their stone had been 
surgically removed. This could also suggest that calculi per se are not major factors of 
urinary microbiota profiles, or the time gap of three months was too long to identify the 
perioperative disruption of the urinary microbiota. This will be further investigated this in 
the next chapter. 
To my knowledge, this is the first study reporting the longitudinal changes of the urinary 
microbiota. The understanding of the relative resilience of urinary microbiota is crucial 
when further studying the effect of antibiotics, surgical intervention and stone 
fragmentation to the urinary microbiota, as explored in the next chapter. 
In the last series of studies in the present chapter, culture-based methods were compared 
to sequencing-based techniques. In most cases, the results overlapped, in the sense that 
the culture-retrieved species were invariably identified among the five most predominant 
OTUs obtained by sequencing. However, exceptions did exist as the case of Weeksella 
species which only consisted of 1.32% of the total reads. This demonstrated the 
sensitivity differences of culture-based methods and sequencing-based techniques. The 
former, although unable to culture all species, was sensitive enough to recover even one 
single microbial cell, at least in theory. While sequencing-based methods tended to lose 
their detection accuracy for microbes at very low abundance since the reagent noise was 
at 103 copy/ml. Therefore, if the microbe of interest can be cultivated, the culture-based 
methods have higher sensitivity than sequencing-based techniques in microbial detection. 
On the other hand, there’s no single culture method that could cover all spectrum of 
known microbes, making it time-consuming work. Therefore, sequencing techniques can 
act as a “guide” for specific culture methods to be employed to recover microbes of 
interest. 
In conclusion, urine samples for microbiota studies should be stored in centrifuged pellet 
form. The urinary microbiota has gender-specific features, and have relative resilience in 
its microbial structure over time. No specific microbiota profiles were identified in this 
study.  
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Chapter 4  
4 Perioperative urinary microbiota and its association with 
infectious complications following extracorporeal shock 
wave lithotripsy of metabolic stones. 
4.1 Introduction 
Urolithiasis, also known as urinary stones, is among the most common urological 
conditions (Scales et al., 2012). In the United States, urinary stones take up about two 
million outpatient visits annually. The incidence seems to be on the rise, in the United 
States, from 3.8% in 1976-1980 to 8.4% in 2007-2010 (Scales et al., 2012; Stamatelou et 
al., 2003). The condition has a detrimental effect on the kidney, with obstruction 
compromising renal functions, which can lead to renal failures. Studies have shown that 
28% of staghorn calculi (a large stone that takes up more than one calyx) patients will 
develop renal function deterioration in eight years (Teichman et al., 1995). Urinary 
stones can also induce infections due to urinary stasis. This can develop into lethal 
urosepsis (O’Keeffe et al., 1993).  
Bacterial infections have themselves been associated with certain types of urinary stones. 
These are usually called “infections stones or struvite stones”. These are thought to be 
caused by urease-producing bacteria (Naber et al., 2011), although this has recently been 
challenged because these microorganisms are not always recovered from the stone 
(Yoshida et al., 1984).  
The chemical composition of infectious stones can comprise mono-ammonium urate, 
struvite (magnesium ammonium phosphate) and carbonate apatite. Common urease-
producing bacteria causing infection stones include E.coli, Proteus species, Klebsiella 
species, Staphylococcus species, and Pseudomonas species, etc. (Bichler et al., 2002). 
Other stone types, for example, those composed of calcium oxalate are thus considered 
“non-infective stones”. They are believed to form without microbial involvement. 
However, despite meticulous preoperative screening and prophylaxis, infective 
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complications still occur frequently, following lithotripsy surgery (Borghi et al., 2012; 
Golechha et al., 2001). 
Common surgical options for urinary stone management include extracorporeal shock 
wave lithotripsy (ESWL), percutaneous nephrolithotomy (PCNL) and endoscopic 
procedures.  
Firstly introduced in the early 1980s (Chaussy et al., 1984), ESWL has revolutionised the 
treatment of urinary stones. Its ease of use, non-invasive nature and high efficiency have 
rapidly won global acceptance. Despite these advantages, complications can occur in 
three categories: stone fragment-associated complications, infection-associated 
complications and tissue damage (Table 8). Infectious complications include bacteriuria, 
UTI and sepsis. For the more serious complications such as sepsis, bacteria in urine enter 
the bloodstream facilitated by renal trauma and vascular disruption induced by the 
ESWL. This is especially the case for infectious stones, where bacteriuria can be detected 
through postoperative urine culture (Michaels et al., 1988). However, even in non-
infection stone patients, postoperative bacteriuria still happens in 5.8% of cases (Mira 
Moreno et al., 2014). In 1997, Pearle et al. performed a meta-analysis performed on eight 
randomised controlled trials (RCTs) investigating the effect of antibiotic prophylaxis on 
ESWL patients, concluded that antibiotic prophylaxis is beneficial and reduces the post-
ESWL complication rate (Pearle & Roehrborn, 1997). This led to the American 
Urological Association (AUA) recommending antibiotic prophylaxis for ESWL until 
2012 when new evidence questioned the efficacy (Honey et al., 2013; Lu et al., 2012; 
Wiesenthal et al., 2011). Today, both the AUA and European Association of Urology 
(EAU) guidelines do not recommend antibiotic prophylaxis, unless the patient has an 
increased risk of infection. 
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Table 8. Common complications following ESWL and PCNL (Skolarikos et al., 
2006) 
Complications after ESWL for urinary stones  
Related to stone fragments 
• Incomplete fragmentation 
• Residual stone fragments 
• Steinstrasse 
• Obstruction  
Infections 
• Asymptomatic bacteriuria 
• Urinary tract infection  
• Sepsis 
Tissue effects 
• Renal (hematoma, hemorrhage) 
• Cardiovascular effects 
• Gastrointestinal effects 
• Genital system 
• Foetus 
Complications after PCNL for urinary stones 
Acute 
• Damage to vascular endothelium 
• Damage to nephron, renal tubules and interstitium 
• Loss of corticomedullary demarcation 
• Increased extraction in urine of metabolites indicating renal damage 
• Haematuria  
• Hematoma 
• Decrease in GFR 
• Decrease in effective RPF 
Chronic  
• New onset of hypertension 
• Perirenal fibrosis 
• Loss of renal function 
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Compared to ESWL, PCNL is a surgical procedure required to remove larger stones or 
those refractory to non-invasive procedures. Infective complications of PCNL are more 
common, in that one-third of cases have an infection-related episode (Cadeddu et al., 
1998). Despite the fact that only struvite stones are currently considered as having a 
bacterial nidus, bacteria have been detected in other common stone types, such as 
calcium oxalate and calcium phosphate stones (Bratell et al., 1990; Dewan et al., 1997; 
Gault et al., 1995; Hugosson et al., 1990; Larsen et al., 1986; Lewi et al., 1984; 
McCartney et al., 1985). During lithotripsy, stone fragmentation may potentially release 
bacteria  into the bloodstream, increasing the risk of urosepsis. Therefore, evaluating the 
risk of postoperative UTI especially urosepsis is of importance. In routine practice, a 
urine culture is usually performed one week prior to surgery to exclude active infection, 
and antibiotic prophylaxis (commonly fluoroquinolones) is applied if positive. Patients 
do not typically undergo their surgery until the urine culture is clear of any evidence of 
infection, as the EAU guidelines recommend (Türk et al., 2017). Despite these efforts, 
life-threatening systemic infections can occur after lithotripsy surgery. This raises the 
question whether there are bacteria present in non-infectious stones that contribute to 
postoperative bacteriuria and other infective complications. 
In this study, we hypothesise that bacteria exist within non-infectious stones, such as 
those composed of calcium oxalate and phosphate are released into urine during 
lithotripsy surgeries. We sought out to determine whether their 16S rRNA gene 
sequencing and enhanced culture from urine and stone samples would be able to detect 
these organisms. 
4.2 Materials and methods 
4.2.1 Clinical samples and study design 
The protocol of this study was approved by the human research ethics board, Western 
University, Canada and West China Hospital, Sichuan University, China. Participants in 
this study were patients admitted to St. Joseph Hospital or West China Hospital. 
Inclusion criteria were that the participants: at least 18 years of age, non-pregnant, no 
other infectious diseases, not receiving antibiotic or chemotherapy. The diagnosis of 
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urinary stone was confirmed with the radiological investigation, and the patient then 
received either ESWL or PCNL. Patient information including gender, age, 
comorbidities, size of the stone along with number, location and composition of the 
stones were recorded. After inclusion, participants in the ESWL group were asked to 
provide three urine samples: one in the operating room before ESWL, plus one collected 
as the first voided urine after ESWL, and one at the follow-up outpatient clinic. 
Participants of the PCNL group provided preoperative voided urine 1-3 days before the 
surgery, and a postoperative urine collected via Foley catheter within 24 hours of surgery. 
A renal pelvic urine sample and a stone sample were also collected during the PCNL 
surgery. Complications were noted from medical records. All patient information was 
maintained by a research coordinator, and were blind to other members of the research 
group until all sample processing, and DNA sequencing work was completed. Patients 
were de-identified after retrieval of their demographic information for statistical analysis. 
4.2.2 Sample collection 
4.2.2.1 Voided urine 
All participants were instructed to wash their hands thoroughly with soap and water, then 
to clean and wash their external genitalia with an antiseptic towelette. Urine samples 
were taken with a clean-catch, midstream voided fashion: the first 10 mL was discarded, 
the majority of the voided volume collected in a sterile container, and the final voided 
volume dispensed into the toilet. Once collected, all urine samples were processed within 
one hour. Microbiological cultures were performed subsequently, and the remaining of 
urine samples were spun down to pellets and stored at -80 ℃. 
4.2.2.2 Renal pelvic urine samples 
During PCNL surgeries, after the ureteral catheter were inserted the patient and set in 
prone position. At this point, after sterile preparation, the percutaneous access was 
established with a 14-gauge Kellet needle. When the needle tip reached the renal 
collection system, urine was emitted from the rear end of the needle, and collected as the 
renal pelvic urine sample. 
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4.2.2.3 Stone samples 
Urinary stone fragments were collected during PCNL, and transferred by the surgeon or 
nurse to a sterile container using aseptic techniques. Stone samples were then transferred 
to the lab, where the procedures for cultural analysis was performed within 4 hours. In 
brief, the surface of the stone was washed five times with sequential falcon tubes 
containing 75% ethanol in the first one and DNA-free water in the remaining four tubes. 
The stone fragments were then transferred to a sterile mortar, crushed, then aliquoted for 
traditional or EQUC culture analysis and 16S rRNA gene sequencing.  
4.2.3 Microbiological culture 
All collected samples were quantitatively cultured on self-made Colombia Blood Agar 
with 5% sheep blood, LB agar and MacConkey agar. Urine samples with a CFU > 105 
per mL were considered to represent an active UTI and excluded, as per standard 
protocol (Pickard et al., 2016). All cultivated strains were isolated and stored. EQUC was 
also applied following protocols developed by Hilt et al. (Hilt et al., 2014). In brief, urine 
samples were cultured with higher volume input (100 ul and up to 1 ml), enriched culture 
media (CBA, CAN agars and thioglycolate medium), both aerobic and anaerobic culture 
atmosphere and extended culture time (up to 5 days). Morphologically unique colony-
types were re-isolated for taxonomic identification. The details of microbiological culture 
media used in this study are in the appendix. 
4.2.4 DNA extraction 
The samples were thawed on ice and DNA-extracted with MOBIO Powersoil® kit. The 
DNA extraction protocol was similar to ones used in Chapter three. In brief, lysis buffer 
and beads were added to urine or urine pellets. Lysis of cells was achieved with 
mechanical and chemical methods. The suspension was then transferred to a new tube, 
and the subsequent procedure was following manufacturer’s instructions.  
4.2.5 16S rRNA gene library generation and sequencing 
Extracted DNA from the clinical samples were PCR-amplified with barcoded primers as 
described by Gloor et al. (2010) shown in Appendix A. The PCR was performed in a 42-
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μl reaction system, with details listed in Appendix B. Following PCR, the amplicons 
were quantified with the Qubit 2.0 fluorometer (Invitrogen, CA, USA). Equimolar 
amounts of each amplicon were aliquoted into a single tube purified with the QIAquick 
purification kit (Qiagen, Mississauga, ON, Canada). Each product was then pooled and 
sequenced on the Illumina Mi-Seq platform in a paired-end run using a 600 cycle kit with 
a paired-end 220-bp run at the London Regional Genomics Center (Robarts Research 
Institute, London, ON, Canada), following standard operating procedures. 
4.2.6 Sequence processing and taxonomic assignment 
Description of the processing algorithm has been previously published (Gloor et al., 
2010). The SOP and related software are accessible at 
http://github.com/ggloor/miseq_bin. The sequences were processed following algorithm 
as stated in Appendix C. Paired-end reads were overlapped with Pandaseq V2.5 (Masella 
et al., 2012), allowing no ambiguous positions in the overlapped reads. Reads were then 
demultiplexed and tagged with the name corresponding to the sample identifier and 
barcode. After demultiplexing, reads from all samples were merged into one single file 
and were clustered into individual sequence units (ISUs), which were then further 
grouped into operational taxonomic units (OTUs) with open reference OTU picking 
method, using Uclust algorithm of USEARCH version 7, which has a de novo chimera 
filtering step built into it (Edgar et al., 2010; Edgar et al., 2015). The identity threshold 
was 97%. Singleton OTUs and ones with abundance < 1% were discarded. Taxonomical 
assignment was performed with mothur 1.3.4 to annotate the OTU sequences against the 
Silva database (v119). 
4.2.7 Bioinformatic analysis 
Compositional data transforming was done using centred log ratios (clr) by custom R 
codes, linear sample independence, and normalization of read counts. K-means clustering 
of the data was performed using Euclidean distances on CLR-transformed data with a 
uniform prior of 0.5 added to each value before transformation. The ALDEx R package 
version 2 was used to compare the relative abundances of genera (fernandes et al., 2014). 
Values reported in the manuscript represent the expected values of 128 Dirichlet Monte-
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Carlo instances of clr-transformed data. A value of zero indicated that organism 
abundance was equal to the geometric mean abundance. Thus, organisms more abundant 
than the mean would have positive values, and those less abundant than the mean would 
have negative values. Base 2 was used for the logarithm so that differences between 
values would represent fold changes. Significance was based on the Benjamini-Hochberg 
corrected P value of the Wilcoxon rank test (significance threshold P < 0.1) (Gloor et al., 
2017).  
4.2.8 qPCR estimation of 16S rRNA gene copy numbers. 
The bacterial load in the urine samples were estimated by qPCR quantification of the 
DNA extracts. The reaction system includes 10ul of PCR master mix, 5 ul of 800Nm 
primer stock (V6 hypervariable region of 16S rRNA gene: V6-LT 5’ - 
CCATCTCATCCCTGCGTGTCTCCGACTCAGNNNNNCWACGCGARGAACCTTA
CC3’ 
and V6-RT: 5’CCTCTCTATGGGCAGTCGGTGATACRACACGAGCTGACGAC 3’) 
Apprill et al., 2015), 5ul of sample DNA template. A standard curve was constructed 
using the values returned using the above methodology with known copy numbers of 
E.coli DH5a gDNA.  
4.3 Results  
4.3.1 Characterization of urinary microbiota of urinary stone patients 
receiving ESWL 
A total of 57 urine samples from 21 urinary stone patients receiving ESWL were 
collected. The median age of participants was 53. After exclusion of urine samples that 
had positive preoperative routine urine culture results, sequencing results of 51 urine 
samples from 12 male and five female stone patients went through downstream 
bioinformatic analysis. A total of 414 OTUs were identified from the returned sequences. 
On average, each sample contained 1938 DNA sequencing reads. 
The composition of the urinary microbiota appeared to be similar to those detailed in 
other chapters. The female urinary microbiota had a comparatively higher alpha diversity 
129 
 
 
than males and was commonly predominated by Lactobacillus species. The male urinary 
microbiotas were usually predominated by a single genus, commonly Corynebacterium, 
Staphylococcus or Streptococcus (Figure 31). qPCR quantification of 16S RNA operon 
copy numbers showed that voided urine samples from female donors had a slightly 
higher copy number of rRNA operons than males, irrespective of healthy or stone status, 
but this was not statistically significant (Figure 32). 
The sequencing results had considerable overlap with the EQUC results of the urine 
samples. A total of 24 isolated strains from nine genera were cultured, with the majority 
of which also confirmed in 16S rRNA gene sequencing (Figure 33). The overlap of 
sequencing and culture results further confirmed the evidence of viable bacteria 
inhabiting in the urinary tract of urinary stone patients.  
4.3.2 Immediate postoperative urine showed signs of bacteria 
released into urine 
The urinary microbiota profile immediately before and then after ESWL was undertaken 
with urine samples from 17 urinary stone patients receiving ESWL. The Shannon index 
was calculated as alpha diversity (species richness and evenness of a given sample) and 
weighted UniFrac phylogenetic distance metric as beta diversity (the difference of 
species composition between two samples) of immediate preoperative and immediate 
postoperative samples. The alpha diversity of immediate post-operative urine samples 
demonstrated remarkable change comparing to preoperative samples. The follow-up 
samples, on the other hand, had their Shannon diversity index score more similar to 
preoperative samples, making the difference of Shannon diversity index score between 
follow-up samples and preoperative samples significantly lower than the difference 
between immediate post-operative samples and preoperative samples (Figure 34).The 
beta diversity of urine samples before and after ESWL demonstrated similar fluctuations. 
The weighted Unifrac distances of samples from one donor at various time points were 
measured. The weighted UniFrac distances between immediate postoperative samples 
and preoperative samples were significantly higher than distances between follow-up 
samples and preoperative samples (Figure 35).  
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Of the immediate postoperative samples, there were OTUs that were not present in 
preoperative samples and reagent controls, or only constituted a small proportion in the 
preoperative samples. In the 16s rRNA gene sequencing results, 12 of 17 immediate 
postoperative samples had increased relative abundance of certain taxa, and in 7 of these 
12, the microbial taxa with relative abundance change were retrieved using culture-based 
methods (routine urine culture and EQUC) (Table 9).  This group of immediate 
postoperative urine samples that have “microbial fluctuation”, also had higher weighted 
UniFrac distances to preoperative urine samples compared to the rest of the immediate 
postoperative urine samples (Figure 36). However, no significant difference in qPCR-
estimated 16s rDNA operon copy number was observed. (Figure 37). In summary, these 
results suggest the release of microbes into urine during ESWL. 
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Figure 31. Relative abundance taxa bar plot of urine samples from urinary stone 
patients receiving extracorporeal shock wave lithotripsy (ESWL). Taxa (groups of 
16s rRNA gene sequences) are represented at the genus level. The dendrogram 
represents the hierarchical average-linkage clustering of the microbiota profiles 
based on the computed weighted UniFrac distances. 
132 
 
 
 
1
6
S
 r
D
N
A
 o
p
e
ro
n
 c
o
p
ie
s
/p
e
ll
e
t
reagent Female Male
100
101
102
103
104
105
106
107
108
109
 
Figure 32. qPCR estimation of bacterial load in urine pellet samples. The result was 
reported as the estimated number of operon copies of 16S rRNA present per urine 
pellet. Bars in plot indicate median and interquartile range 
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Figure 33. Heatmap comparing taxa detected by 16S rRNA gene sequencing and 
culture-based techniques. Each square was colour-coded based on the detection 
status of a given taxa. Green means detected by sequencing only, red means detected 
by both methods, blue means detected by culture only and grey means not detected 
by either method. 
 
134 
 
 
S
h
a
n
n
o
n
's
 d
iv
e
rs
it
y 
in
d
e
x
Pre-Op Immediate post-Op Follow-up
0
1
2
3
4
5
C
h
a
n
g
e
 i
n
 S
h
a
n
n
o
n
's
 d
iv
e
rs
it
y
 i
n
d
e
x
Immediate post-Op Follow-up
0
1
2
3
4
a. b.
 
Figure 34. Shannon’s diversity of urine samples from stone patient receiving ESWL. 
(a) Change in Shannon’s diversity of urinary microbiota before and after ESWL. 
Samples from one donor were connected by lines. (b) Dot plot shows differences of 
alpha diversity from immediate post-operative samples and follow-up samples to 
pre-operative samples. 
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Figure 35. Dot plot showing weighted UniFrac distances index between preoperative 
samples to immediate postoperative samples and follow-up samples. Each dot stands 
for the weighted UniFrac distances index from the current condition (immediate 
post-operative or follow-up) to the preoperative urine sample from the same donor.  
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Table 9. Changes in relative abundance of taxa in immediate postoperative urine 
samples. 
Donor Urotype Postoperative sequencing 
fluctuation 
Culture results 
1 Staphylococcus Enterobacteriaceae spp. Staphylococcus 
2 Streptococcus 
 
Streptococcus 
3 Gardnerella Enterobacteriaceae spp.， 
Lactobacillus 
Enterobacteriaceae spp. 
4 Corynebacterium 
 
Corynebacterium 
5 Streptococcus Pseudomonas Streptococcus, Pseudomonas 
6 Corynebacterium Staphylococcus Corynebacterium, Staphylococcus 
7 Corynebacterium Enterobacteriaceae spp. 
 
8 Gardnerella Staphylococcus Gardnerella, Staphylococcus 
9 Gardnerella Actinobaculum Gardnerella, Actinomyces 
10 Streptococcus Staphylococcus Streptococcus, Enterobacteriaceae 
11 Corynebacterium 
  
12 Lactobacillus Enterobacteriaceae spp. Enterobacteriaceae spp.， Lactobacillus 
13 Lactobacillus 
 
Lactobacillus 
14 Lactobacillus Porphyromonas Pseudomonas, Weeksella 
15 Lactobacillus Staphylococcus, Actinobaculum Staphylococcus, Lactobacillus 
16 Corynebacterium 
 
Enterobacteriaceae spp. 
17 Lactobacillus Staphylococcus Enterobacteriaceae spp.,Gardnerella 
* In this table, “Urotype” shows the most predominant taxa in the 16s rRNA gene sequencing result, 
and “Postoperative sequencing fluctuation” shows taxa that have the highest degree of change in 
their relative abundance in the in the 16s rRNA gene sequencing result. “Culture results” showed 
strains isolated from routine urine culture and EQUC. 
136 
 
 
U
n
if
ra
c
 D
is
ta
n
c
e
s
 t
o
 P
re
-o
p
 s
a
m
p
le
s
Immediate post-Op Follow-up Immediate post-Op Follow-up
0.0
0.2
0.4
0.6
"Microbial fluctuation" Others
 
Figure 36. Comparison of weighted UniFrac distances of urine samples between 
groups that have “microbial fluctuation” in immediate postoperative samples. That 
is, taxa that have a remarkable increase in relative abundance and also confirmed in 
culture-based methods, and other samples. Each dot in the plot represents the 
weighted UniFrac distance of this sample to the preoperative sample of the same 
donor. 
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Figure 37. qPCR estimation of bacterial load in immediate postoperative urine 
samples. The “microbial fluctuation” groups stand for urine samples that have taxa 
with a remarkable increase in relative abundance and confirmed by culture-based 
methods. The result was reported as the estimated number of operon copies of 16S 
rRNA present per urine pellet.  
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4.3.3 Correlation of stone and urine microbiota profile further 
confirmed bacteria in stone 
To further confirm that the post-ESWL detected bacteria cames from the stones, pelvic 
urine samples and stone samples were collected together with preoperative and 
postoperative voided urine sample from six patients receiving percutaneous 
nephrolithotomy (PCNL). Of these, the stone samples of two patients of six patients had 
positive 16S rRNA gene sequencing results (i.e., a microbiota profile distinct from reagent 
control profiles).  
The first patient was a 46-year-old male whose preoperative urine sample presented a 
Corynebacterium-predominated profile, while his stone sample had DNA sequences 
attributable to Staphylococcus. The pelvic urine samples and voided postoperative urine 
sample also had a high proportion of Staphylococcus in sequencing results which coincided 
with the stone sequencing results.  
The second patient was a 52-year-old female whose preoperative voided urine sample was 
predominated by Gardnerella and Lactobacillus. The stone microbiota consisted mainly 
of Actinobaculum and Enterobacteriaceae spp, which are also major components of the 
urinary microbiota in the patient’s pelvic urine and a postoperative voided urine sample 
(Figure 38).  
These results suggest that it is highly likely that the newly-emerged bacteria in the 
postoperative urine may come from the stone during lithotripsy. 
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Figure 38. Relative abundance taxa bar plot show microbiota profiles from two 
PCNL patients kidney stones plus various urine collections.  
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4.4 Discussion  
 In this study, the urinary microbiota was noted to fluctuate following lithotripsy surgery, 
suggesting the origin of the bacteria was the stone itself. 
Traditionally, urinary bacteria have not been implicated in calcium oxalate or calcium 
phosphate stones. However, postoperative infective complications do happen after 
lithotripsy surgeries, despite negative preoperative urine culture and antibiotic 
prophylaxis. Several studies now have reported that bacteria can be isolated from non-
struvite urinary stone samples, even with routine urine culture methods (Mariappan et al., 
2005; Mufarrij et al., 2012; Songra et al., 2016). These reports suggest the existence of 
bacteria in “non-infective” stones. In our study, we observed a “microbial fluctuation” 
phenomenon in the immediate postoperative urine samples, that is, an increase in relative 
abundance of several microbial taxa that either did were not present before ESWL or 
were in low abundance.  
When designing the study, attempts were made to eliminate confounding factors that 
could have an impact on the urinary microbiota. None of the patients in this study was 
receiving antibiotic prophylaxis during ESWL. Since ESWL uses externally applied 
focused shock wave to fragment the stone, no invasive instrumentation or procedures 
were taken during stone fragmentation in ESWL. This setting excluded most factors that 
affect the urinary microbiota. Although, theoretically bacteria could be liberated from 
epithelial cells during lithotripsy, the correlation of stone and urine sequencing results 
suggested that the “microbial fluctuation” likely resulted from the fragmentation of the 
stone.  
It was interesting to note the correlation of microbiota profiles between stone samples, 
renal pelvic urine samples and immediate postoperative samples. The microbiota 
associated with stones and upper tract urine samples had different features than 
preoperative voided urine samples: the latter was invariably similar to the genitalia: 
Lactobacillus-predominant for female, and Corynebacterium or Staphylococcus for a 
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male. The stone samples and “microbial fluctuation” taxa in postoperative urine samples 
in our study, on the other hand, had Staphylococcus, Actinobaculum, Pseudomonas and 
Enterobacteriaceae spp. (presumtively E.coli) as the major taxa in sequencing results. 
Barr-Beare et al. (2015) sequenced stones from five paediatric patients and found 
Enterobacteriaceae, Pseudomonas, Gardnerella, Bradyrhizobium, Phyllobacterium and 
Brucella 16S rRNA gene homologies. Of note, many of these stone-associated microbes 
are known uropathogens (Kass et al., 2002; Salem et al., 2015; Tavassoli et al., 2012; 
Woolfrey et al., 1986), which again links UTI and urinary stone formation. Urinary stone 
patients are more likely to develop UTIs (Holmgren et al., 1989; Hugosson et al., 1989), 
and stone culture studies also showed 19-32% of calcium oxalate stones are bacteria 
positive (Tavichakorntrakool et al., 2012; Wang et al., 2014). Barr-Beare et al. 
(2015)also showed that bacteria and urinary stones have mutual facilitating effects on 
their pathogenesis progress in the formation of calcium oxalate crystals. The role of 
bacteria in the formation of calcium oxalate and other non-infective stones warrants 
further study. 
Post-ESWL bacteriuria and bacteremia are not uncommon for patients with infection 
stones (Michaels et al., 1988; Müller-Mattheis et al., 1991). However, the incidence of 
postoperative bacteriuria for non-infection stone patients is as low as 5.8%, when using 
routine urine culture methods (Mira Moreno et al., 2014). In our study, the postoperative 
“microbial fluctuation” phenomenon was identified from 70.6% of postoperative urine 
samples(12 out of 17), and both 16S rRNA gene sequencing and EQUC could detect this 
“microbial fluctuation” phenomenon in 41.2% of all immediate postoperative urine 
samples (7 out of 17 samples), suggesting a higher sensitivity than traditional culture 
methods. Admittedly, the “microbial fluctuation” phenomenon observed in this study is 
much milder than the traditional definition of bacteriuria, as it neither reached the 
required CFU threshold on routine urine culture nor caused any symptoms.  
In summary, some patients with non-infection urinary stones appear to have bacteria 
released from their kidney stones when disrupted by ESWL. This has clinical 
ramifications if release of these organisms induces infection. The results should not be 
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taken as recommending antibiotic prophylaxis for all stone patients, as it is not clear that 
these drugs will prevent infection, or that their use is justified if the infection rate is low. 
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Chapter 5  
5 General Discussion 
5.1 Study of the microbiota in the urinary tract 
5.1.1 Problems of applying 16S rRNA gene sequencing analysis to 
low abundance microbiota 
The introduction of culture-independent, sequencing-based microbial analytic methods 
has greatly reshaped the understanding of microbes inhabiting a human body that many 
of these microbes can’t be retrieved by routine traditional microbial culture methods. The 
awareness that not all bacteria present in clinical samples could be cultivated dates back 
to “The Great Plate Count Anomaly” phenomenon that microscopically identified 
microbial cell numbers might not coincide with the number of colonies in the Petri plates 
(Staley & Konopka, 1985). Now with the power of sequencing-based techniques, the 
number of bacterial phyla (i.e., the highest level of taxonomical divisions under bacterial 
kingdom) has increased from 11 in 1987 to at least 85 at present, with many that have 
still to be cultivated (Achtman & Wagner, 2008; Keller & Zengler, 2004; Rappé & 
Giovannoni, 2003; Woese, 1987). These findings further promoted the investigation of 
the presence of bacteria at sites considered likely to be microbes-rich, including brain, 
breast tissue, blood, placenta and subepidermal tissue etc. in human body (Aagaard et al., 
2014; Branton et al., 2013; Emery et al., 2017; Justesen et al., 2010; Nakatsuji et al., 
2013). Most of these studies claim the existence of “tissue-associated microbiota”, and 
their potential role in the pathogenesis of diseases. However, a study by Salter et al. 
revealed that a remarkable proportion of sequencing reads were attributed to background 
noise from environment and reagents (Salter et al., 2014). This study revealed the 
awareness of increased risk in analysing samples with low microbial biomass (Weiss et 
al., 2014). 
In this study, we further demonstrated that besides contamination from environment and 
reagent, the host DNA could also compromise the quality of microbiota study in multiple 
levels. 
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First, we showed that high host DNA abundance would saturate commonly-used DNA 
extraction kit columns. These extraction kits rely upon columns that have silicone filters 
to bind the DNA from the sample. Two of the most commonly used DNA extraction kits 
for gut microbiota studies include the Qiagen QIAamp® and MOBIO Powersoil® (now 
Qiagen) products. The QIAamp® column has a binding capability of up to 4-12 ug DNA 
per filter, whereas, the Powersoil® has a capacity up to 20 ug per filter (Manufacturer’s 
manuals). Given that most gut microbes have a genome size around 4-6 Mb, this binding 
capability could retrieve presumably as high as 109 copies of bacterial gDNA, which 
when amplified, sequenced and analysed would provide a reliable representation of gut 
microbial communities. However, when it comes to tissue samples with low prokaryotic 
and high eukaryotic cell components, given that eukaryotic cells have a much higher 
genome size (e.g. 3000 Mb homo sapiens genome), a DNA collection filter as used in a 
commercial extraction kit, could only hold the DNA contents of around 6.5 x 106 cells in 
theory. If we assume that the rate of binding is the same for bacterial to host DNA, it 
would mean that only a small amount of bacterial DNA would be captured because the 
binding capacity of the column would rapidly be exhausted by the eukaryotic DNA. 
Since one gram of solid tumor is estimated to have 108 to 109 cells (Del Monte et al., 
2009; Rasnick et al., 2002), therefore, a common input of 200 ug of this tissue as used in 
some of our studies, could contain 2 x 107 to 2 x 108 cells, rapidly saturating the DNA 
extraction columns. Given this and the low prokaryotic/eukaryotic cell ratio, the 
prokaryotic DNA yield could be very low in these columns and bear the risk of poor 
representation of the sample microbial communities that they are obtained from and the 
importance of confirmatory analysis by culture.  
Secondly, we showed that the presence of disproportionately high host DNA abundance 
inhibits PCR amplification when using the bacterial specific 16S rRNA gene primers. 
The inhibiting effect of non-target DNA on PCR amplification performance is well 
known in molecular biology (Ludwig & Schleifer, 2000). However, compromised 
microbial rRNA gene amplification seems to be less recognised. Grice et al. (2008) 
reported that a eukaryotic/prokaryotic gDNA ratio of 1 to 100 would not significantly 
alter 16S rRNA gene amplification, however, our data shows that as the ratio continues to 
increase, amplification efficiency drops remarkably when eukaryotic/prokaryotic gDNA 
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ratio above 103 (Figure 6a and 6b in Chapter Two). Samples with a higher ratio would 
have a poor microbial community representation after DNA extraction and PCR 
amplification (Figure 6c and 6d). 
Thirdly, we showed that the unspecific amplification of host DNA could take a 
remarkable proportion of the sequencing depth. Host DNA consuming sequencing depth 
is a known issue in whole genome sequencing and RNA sequencing (Feehery et al., 
2013). Studies with whole genome shotgun sequencing in the presence of large amounts 
of host eukaryotic DNA have shown that the background DNA will consume significant 
amounts of sequencing depth, making sequencing inefficient, time-consuming and 
inaccurate (Feehery et al., 2013). From these studies, it appears that the sequencing depth 
of 16S rRNA gene sequencing the presence of a high predominance of host DNA is also 
compromised. 
Besides host DNA, samples with low microbial biomass are associated with risks of poor 
sequencing results as well. Recently Salter et al. showed that a low level of background 
DNA contamination is ubiquitous and almost inevitable for a sequencing-based 
microbiota studies (Salter et al. 2014; Weiss et al., 2014). Fecal samples have 
tremendously rich microbial content, whose 16S rRNA gene sequencing reads will 
indubitably overshadow the background noise. However, samples with low microbial 
biomass have their microbial DNA at a comparable level to contaminating DNA and is 
thus more vulnerable to sequencing bias and within-sample heterogeneity (Kennedy et 
al., 2014). In fact, as microbial gDNA concentration in a sample goes lower, the reads 
from background contamination will take increasing proportions of the result, which will 
lead to a complete background contamination sequencing result for an extremely low 
abundance sample (Salter et al., 2014). It is, therefore, important to identify a lower limit 
of the microbial biomass of samples that could yield a decent sequencing result. We thus 
recommended sequencing serially diluted mock samples to identify this lower limit, then 
estimate the sequencing quality before the sequencing the samples. 
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5.1.2 Value of an optimised sample processing algorithm 
As the fore-mentioned risk factors exist, processing samples with the high host to low 
bacterial gDNA ratios (“high-low” samples) with a protocol similar to ones used in the 
gut microbiota studies may greatly compromise analysis quality. Therefore, an adapted 
protocol is required. In the second part of Chapter Two, we developed a quality-checking 
tool and a refined algorithm which is considerate of these sample types. The aim of the 
refined algorithm is to mitigate the negative effect of high host DNA abundance and low 
microbial biomass.  
The photo-activated DNA binding compound, propidium monoazide (PMA) has 
previously been used in microbiota studies when analyzing environmental samples with 
very low estimated microbial biomass, including ocean (Galand et al., 2009), cleanroom 
environments (Weinmaier et al., 2015), and even international space stations(Checinska 
et al., 2015; Venkateswaran et al., 2014) . It has been used to differentiate DNA from 
living microbial cells to that from free extracellular DNA or DNA present within dead 
cells (Emerson et al., 2017). Living microbial cells have intact cell membrane, which 
prevents PMA cellular uptake and subsequent DNA binding. This technique is also being 
used in fluorescence staining with flow cytometry, where the proportion of living 
microbes in drinking water are approximately 70-80% (Berney et al., 2008; Luna et al., 
2002; Yokomaku, Yamaguchi, & Nasu, 2000), and 50-60% in surface fresh water, 
estuarine and coastal marine stations (Freese, et al., 2006; Schumann et al., 2003). The 
limitation of this membrane integrity-based technique includes (1). It lacks 
differentiability in dying cells because the membrane does not instantly disintegrate. (2). 
PMA cant evaluate the viability of microbial forms with strong wall structure such as 
spores (Berney et al., 2008; Bosshard et al., 2009; Lisle et al. 1999). 
Microbial DNA enrichment kits are commonly used in whole genome sequencing, where 
eukaryotic host DNA and microbial DNA are both present. Various mechanisms are 
utilised in commercial microbial enrichment kits to deplete eukaryotic DNA. The 
NEBNext® Microbiome DNA Enrichment kit from New England Biolab uses a 
methylated CpG-specific binding protein to bind methyl-CpG that only present in 
eukaryotic cells, while the Molzym's MolYsis kit selectively lyse human cells using 
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chaotropic reagents, then degrades all extracellular DNA with DNase (Thoendel et al., 
2016). Sequencing of 16S rRNA gene amplicon specific primers typically won’t amplify 
human DNA, however, we have shown in chapter two that in “high-low” samples, host 
DNA could inhibit PCR amplification and that unspecific amplification consumes 
sequencing reads. Therefore, microbial enrichment kits remain as a useful tool to deplete 
host DNA when handling “high-low” samples for 16S rRNA gene sequencing. 
Although the techniques mentioned above have been previously reported, here we are 
first to report that silicon-based filters in DNA extraction kits should be avoided.  By 
doing this and substituting for an alternative DNA collection technology, such as the 
traditional ethanol precipitation, much higher microbial DNA yield will be realized for 
these “high-low” samples.  
5.1.3 Verification of a microbiota in renal tissue 
In Chapter two, we examined renal tumour and healthy adjacent tissue from the same 
individuals for the presence of bacterial microbiota. The conventional medical doctrine is 
that the upper urinary tract is considered to be “sterile”. Conditions such as pyelonephritis 
are thought to typically occur where urinary obstruction can be present in the urogenital 
tract and the result of reflux and opportunistic ascending microorganisms. Obstruction 
can be the result of urolithiasis, stricture and the presence of tumours. The former has 
been reported in early investigations of the bacterial composition of kidney stones which 
appear to show the presence of E. coli (Barr-Beare et al., 2015) and is potential evidence 
which suggests that trace amounts of bacteria exist in the upper urinary tract.   
Of note, uropathogens such as E.coli were able to invade into kidney urothelial 
cells(Chassin et al., 2008; Pichon et al., 2009)  and form intracellular bacterial 
communities (Eto et al., 2006) , and then move even deeper and form quiescent 
intracellular reservoirs (Hunstad & Justice, 2010) . In this way, rather than adhering to 
the luminal surface of urothelial cells, bacteria could also move deeper into the 
parenchymal tissue, where they were able to avoid antibiotics and host immune response. 
Bacteria in these reservoirs maintained minimal metabolic activities and usually could 
not be cultivated, but they could restore their activity and cause subsequent recurrence or 
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asymptomatic infection (Lewis et al., 2007). Through the development of DNA 
extraction methods, our study supports the existence of bacteria in renal parenchyma 
tissue.  
 
5.2 Urinary microbiota profiles of healthy individuals and 
urinary stone patients 
5.2.1 Urine sample storage form and sequencing quality 
Sample processing and storage methods are arguably the most critical steps in microbiota 
studies since it has a high risk of influencing microbial profiles. It has been reported in 
gut microbiota studies that sample storage methods can significantly affect faecal 
microbiota profiles (Choo et al., 2015; Gorzelak et al., 2015; Nsubuga et al., 2004). 
Optimal preparation, handling and storage protocols for stool samples have also been 
proposed as a standard methodology (Gorzelak et al., 2015). Unfortunately, for urine 
samples, there have no optimised storage methods yet reported. In the first part of 
Chapter Three, we performed experiments to investigate how sample volume and storage 
form could affect the microbiota sequencing analysis results. Urine samples with greater 
than 20 ml in volume, which were stored in centrifuged pellets gave the same consistent 
results. Any smaller volumes collected tended to reflect the background contaminating 
sequences to some degree. 
With the exception of stool samples, studies focusing on the optimal preparation, 
handling and storage methods for next generation sequencing-based microbiological 
studies are rather limited. Part of the reason for that is that simple act of culturing urine 
can be performed almost immediately after the samples collection, so there’s no need for 
extended sample storage solutions. However, for sequencing-based microbiota analysis, 
clinical samples are usually processed in batches, making it a requirement to store urine 
samples after collections. As the interest in urinary microbiota grows, it will become 
increasingly crucial to develop a standardised operating protocol (SOP) for the handling 
of urine samples. 
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In most biobank sample handling SOPs, urine samples are collected and stored for 
biomarker detection. Therefore, relatively low volumes are typically captured, and no 
precautions are taken to maintain the viability of microorganisms (Elliott & Peakman, 
2008). In our study, we showed that these conditions are not optimal for microbiota 
studies. Given the relatively low human and microbial cell numbers in a urine sample, the 
volume requirement to capture amounts of microbial gDNA required for a reasonable 
analysis is higher than metabolites analysis. Roewer et al. reported that 200 ml of urine 
are required to perform a human DNA type with multilocus probes (Roewer et al., 1990) 
. Brinkman et al. showed that 10 ml of the urine sample are generally insufficient to 
perform DNA polymorphism using Southern blotting (Brinkmann et al., 1992) . In our 
study, urine samples with a volume higher than 20 ml seem to have a decent 
representation of the urinary microbiota profiles. As a growing number of microbiome 
biobank being established (“Harvard Chan School awarded $4.9 million to create 
microbiome biobank,” the “PennCHOP Microbiome Program,” webpage) , our results 
could be helpful to set their urine sample collection and storage SOPs. 
5.2.2 Longitudinal stability of urinary microbiota 
In our study, we showed that the urinary microbiota from one donor when analysed at 
different time points over three months have high similarity, but much less so than urine 
samples from other donors of similar gender and age. We thus can infer that the urinary 
microbiota has its stability and resilience as an ecosystem. To our knowledge, this is no 
previous study on the ecological stability of the urinary microbiota, but multiple studies 
demonstrated the ability of gut microbiota to recover after a pathological condition or 
iatrogenic procedures (David et al., 2015; Dethlefsen & Relman, 2011; Fukuyama et al., 
2017; Raymond et al., 2016) . Similarly, we also demonstrated the recovery of urinary 
microbiota after lithotripsy surgery in Chapter four. Reported factors contributing to the 
stability of gut microbiota includes topical microenvironment, genetic background, diet 
and host age, etc. (Relman et al., 2012) . in reverse, gut microbiota profiles also reflect 
the health, nutritional and drug administration information of the host (Lozupone et al., 
2012). The urinary microbiota is believed to be shaped and affected by two adjacent 
ecosystem: the gastrointestinal tract and the external genitalia (including vagina in 
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females), as many common urinary inhabitant microbial species can find their 
counterparts in these sites (Dong et al., 2011; Khasriya et al., 2013; D. A. Lewis et al., 
2013; Siddiqui et al., 2011; Willner et al., 2014). Under pathological conditions, these 
two sites also serve as a source of microbial invasion and pathogen reservoir which cause 
UTI recurrence and relapse (Bao et al., 2014).  Other key factors shaping the urinary 
microbiota, on the other hand, awaits further studies. 
In fact, the stability of the ecosystem is a well-discussed topic in ecology. Elton in 1958 
claimed population variability, population recovery, ease of invasion and the 
consequences of invasion as aspects and components of ecosystem stability (Elton et al., 
2000). Pimm et al. set a few criteria of ecosystem stability, including parameters showing 
the system returning to previous equilibrium after displacement, the time for the system 
to return to equilibrium is relatively short, the main parameters of a given system remains 
stable during a displacement, the system has the drive against the displacement, and the 
variation of main parameters over time is limited (Pimm et al., 1991). In our study, the 
urinary microbiota demonstrated its resilience as its alpha and beta diversity index 
(Shannon’s index and Weight UniFrac distance scores) maintained low variation level 
throughout lithotripsy surgery and could return to the pre-disturbance equilibrium in a 
relatively short period (three months or shorter). Recognizing this resilience of urinary 
microbiota is crucial when further investigating how displacing events (such as 
antibiotics and surgical procedures as discussed in Chapter four) affect the urinary 
microbiota and the degree of resilience of urinary microbiota beyond which it can’t 
restore the pre-disturbance conditions. 
5.3 Bacteria in metabolic urinary stones 
In chapter four, we showed that some of the non-infectious, calcium-based metabolic 
urinary stones could also harbour bacteria, as can be observed in immediate postoperative 
urine samples, despite that all these patients have a negative preoperative urine culture. In 
fact, several other studies also reported bacteria in metabolic urinary stones. McCartney 
et al. reported that among 16 patients with calcium oxalate stones and negative 
preoperative urine culture, four of them has positive culture results on their stone samples 
(McCartney et al., 1985). Gault et al. investigated all culture-positive urine stone samples 
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of 258 patients, and found only 43% of kidney stones, none of the ureteric stones and 
50% of the bladder stones contained magnesium ammonium phosphate composition 
(Gault et al., 1995). Hugosson et al. performed stone and urine cultures from 215 patients 
and found among all calcium oxalate phosphate stones 32% has positive stone cultures 
(Hugosson et al., 1990). These results suggest that urinary stone of any composition 
could harbour bacteria and release them during lithotripsy. In our study, we observed a 
“bacterial fluctuation” in immediate postoperative urine samples which contained 
microbial species that could not be detected in preoperative samples. Interestingly, the 
OTUs that showed fluctuation in sequencing correlated with the culture results of stone 
and pelvic urine samples, which further confirmed that the source of these is bacteria 
likely liberated from the stone. We also noticed that stones with routine type culture 
analysis that were positive seemed to have a broader spectrum of microbial species 
identified by 16S rRNA gene sequencing than those that didn’t, potentially demonstrating 
the ability of sequencing-based techniques to characterise microbial populations that are 
not cultivated during routine analysis. 
The findings of bacteria in metabolic stone arouse questions of the role bacteria in the 
metabolic stone formation and whether they a nidus for inflammation leading to crystal 
nucleation. Clinical studies found that urinary stone patients are more likely to have 
UTIs, even though such stones may not cause an obstruction (Holmgren et al., 1989; 
Hugosson et al., 1989). Interestingly, the most common metabolic stone-associated 
bacteria are E.coli, while Proteus species are more common in struvite stones (Gault et 
al., 1995). Barr-Beare et al. showed in a rodent model that E.coli infection caused 
increased kidney calcium oxalate deposits (Barr-Beare et al., 2015). The exact 
mechanism of E.coli inducing metabolic stone formation has yet to be elucidated and 
beyond the scope of this study. 
5.4 Value of voided urine samples in studying the kidney 
stone microbiota and its use in predicting postoperative 
infective complications 
Although most patients had a negative preoperative urine culture before lithotripsy, 
postoperative infective complications are not rare. Many studies have also reported 
156 
 
 
infective complications such as bacteriuria in patients with clean voided preoperative 
urine cultures. Many urinary stone patients also develop infective complications with a 
negative preoperative urine culture (Larsen et al., 1986). Charton et al. documented 35% 
of patients receiving PCNL could develop postoperative bacteriuria, while all these 
patients had negative preoperative urine culture (Charton et al., 1986). Mariappan et al. 
carried out a study among patient receiving ureteroscopic lithotripsy, and found 12 out of 
75 included patients developed postoperative bacteriuria (Mariappan & Loong, 2004). 
Bratell et al. showed that many of the bacterial species cultured from stone samples are 
unidentifiable on voided preoperative urine samples, emphasizing the importance of 
stone cultures (Bratell et al., 1990). Of note, in our studies, most patients had negative 
postoperative urine cultures by routine methods, but 16S rRNA gene sequencing could 
still identify evidence of bacteria liberated from the stone. These results suggested 
metabolic stones release bacteria during lithotripsy, and in many cases, it stayed below 
clinical detection range. In fact, the threshold of a routine urine culture is always under 
some controversy. The commonly used 105 colony forming units (CFU)/mL potentially 
miss many clinically significant infections, and there are also recommendations favouring 
a threshold of 103 CFU/mL (Jungwirth et al., 2012; Schmiemann, Gebhardt, Matejczyk, 
& Hummers-Pradier, 2009). Both of these are subjective determinants. These 
controversies to some extent reflect the difficulty of differentiating the pathogens from 
the bladder or kidney from commensal microbes in urethral and genitalia when using 
voided urine samples. This issue also presents when screening bacteriuria in stone 
patients. Several studies have reported that the microbes isolated from the stone culture 
cannot be identified from voided urine samples (Mariappan et al., 2005; Mufarrij et al., 
2012; Songra et al., 2016). In our study of the paired sequencing of stone and urine 
samples, we can see that OTUs that predominated in the stone sequencing results may 
only occupy a small proportion in the voided urine sample, with the remaining reads 
attributed to the urethra and genitalia-associated species. These may be part of the 
reasons why people claim that voided urine has inferior performance in detection of 
bacteria in stones. Lewi et al. showed that the positive rate of preoperative voided urine, 
stone sample and pelvic urine cultures are 29%, 38% and 30% respectively, with the 
voided urine sample to be the lowest (Lewi et al., 1984). The advantage of the voided 
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urine sample, however, is that (a)  it can be obtained non-invasively, and (b). it can be 
obtained preoperatively for risk evaluation of infective complications. In our study, none 
of the six patients who had their stone samples sequenced had positive post-operative 
urine culture when analyzed by standard culture techniques, however, for the two of the 
patients that had positive stone culture and sequencing results, microbial species that 
presented in stone samples also had their OTUs increased in relative abundance in the 
sequencing results. These results suggested that sequencing-based techniques could 
increase the sensitivity to detect bacteria release from stone during lithotripsy with voided 
urine samples. 
5.5 Future directions 
Detection of microorganisms in very low microbial biomass is always challenging, 
especially when the microbes are fastidious. In our study, we utilised sequencing-based 
techniques to identify the DNA of these microbes in kidney tissues, and undertook 
methodologies to limit contamination by using techniques such as PMA to deactivate any 
extracellular DNA. We then confirmed many of these microbes with enhanced culture 
techniques. The disadvantage of this strategy is the risk of contamination during sample 
handling.  A more direct method would be using staining methods that have live/dead 
differentiation abilities, for sample the viability stains that based on membrane integrity, 
then visualise the bacteria within a tissue section using confocal microscopy. In this way, 
bacteria could be visualised in situ, making it possible to identify their inhabiting locus 
within a given tissue. 
For the stability and resilience of urinary microbiota, one aspect that was not covered in 
our present study is the “elasticity” of the urinary microbiota, i, the degree of disturbance 
or displacement to the urinary microbiota that it could be still able to restore, and the rate 
at which the microbiota returns to its previous conditions. In our study, most of the 
participants maintained their urinary microbiota stability partly because they are either 
healthy individuals or uncomplicated urinary stone patient with relatively low risk of 
severe disturbance. How urinary microbiota responds to a more severe condition, 
including chronic infection with anatomical abnormalities, long-term foreign body 
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implantation, direct connection with gastrointestinal tract such as fistula or urinary 
diversion awaits further study. 
To carry on studies on roles of bacteria on the metabolic stone formation, a cross-
sectional study should be carried out to explore the incidence of metabolic stones 
harbouring bacteria. Multiple studies have reported positive bacterial culture from urinary 
samples, but most of these studies have a relatively small sample size (<= 150 donors) 
(Sohshang et al., 2000; Takeuchi et al., 1989; Tavichakorntrakool et al., 2012; Yoshida et 
al., 1984). Microbiological screening of a larger cohort needs to be applied to confirm the 
observation that E.coli is the most commonly found microorganism in metabolic stones.  
There have been reports that inflammation could promote urinary stone formation 
(Ghazali et al., 1997; Rule et al., 2009). The most extreme case would be the matrix 
stones, which mainly consists of inflammatory proteins (Canales et al., 2009). Metabolic 
stones in the kidney may also induce inflammation by mechanic effects or urinary 
obstruction through Il-1β released by dendritic cells, and urine Il-6 would also be 
elevated (Canales et al., 2010; Mulay et al., 2012). The innate immune reaction may later 
be activated, and the immune proteins may form the inner core of the stone which in turn 
facilitate crystalluria precipitation (Mushtaq et al., 2007). How bacteria may modulate the 
inflammation cascade, and the interaction of immune proteins would be the interest of 
further studies.   
5.6 Final statement 
As our results and other studies have shown, the study of samples with high host DNA 
and low microbial biomass is technically challenging. Described by Joanne et al. as 
“Schrödinger’s microbes”, analysis of microbial composition and function in these 
samples is fraught with complications. Extra caution, meticulously optimised methods 
and combination with enhanced culture methods are required to obtain a relatively 
accurate result. Despite these limitations, sequencing-based techniques remain as a novel 
and sensitive methods for microbiota research, and have the potential for further clinical 
application. 
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Appendices  
Appendix A: Primer details for 16S rRNA gene amplification 
The target of these primer sets was the V4/V6 hypervariable region of the 16S rRNA 
gene: V4-forward, 5’ 
ACACTCTTTCCCTACACGACGCTCTTCCGATCTnnnn(8)GTGCCAGCMGCCGCG
GTAA 3’; and V4-reverse, 5’ 
CGGTCTCGGCATTCCTGCTGAACCGCTCTTCCGATCTnnnn(8)GGACTACHVGG
GTWTCTAAT 3’. V6-forward, 
5′ACACTCTTTCCCTACACGACGCTCTTCCGATCTnnnn(8)CWACGCGARGAACC
TTACC3′; and V6-reverse, 
5′CGGTCTCGGCATTCCTGCTGAACCGCTCTTCCGATCTnnnn(8)ACRACACGAG
CTGACGAC3′. 
In the primers, the first 35-37 capitalized letters were the Illumina paired-end sequencing 
adapters, “nnnn” were four random nucleotides, and “(8)” was a specific sample barcode 
region which allows for sample multiplexing. 
Appendix B: PCR reaction system of V4 amplicon library construction 
The PCR was performed in a 42-μl reaction system, including 2 μl of DNA template (for 
negative controls nuclease-free water was used instead), 0.15 μg/μl of bovine serum 
albumin, 20 μl of 2× GoTaq hot-start colorless master mix (Promega), 10 μl of left and 
right primers (3.2 pmol/μl). Samples were amplified individually with an Eppendorf 
Mastercycler under the following conditions: initial denaturation at 95°C for 2 min 
followed by 25 cycles of 95°C for 1 min, 55°C for 1 min, and 72°C for 1 min. 
Appendix C: The exact workflow for 16S sequencing 
This part is adapted from the supplementary material with permission of  
Bian G, Gloor GB, Gong A, Jia C, Zhang W, Hu J, Zhang H, Zhang Y, Zhou Z, Zhang J, Burton JP, 
Reid G, Xiao Y, Zeng Q, Yang K, Li J. 2017. The gut microbiota of healthy aged Chinese is similar 
to that of the healthy young. mSphere 2:e00327-17. https://doi.org/10.1128/mSphere.00327-
17. 
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Step 1: Download and de-compress the MiSeq reads. Place the reads into the 
reads/directory. Reads are compressed with 7Zip. The following commands were used to 
decompress the file: 
7z e filename  
gunzip XthRun_S1_L001_R1_00.fastq.gz 
Step 2: Overlap the reads with pandaseq v2.5. An example command for this with a 
minimum overlap of 30 nucleotides is below. This command is appropriate for the V4 
amplimers:  
pandaseq -g pandaseq_log.txt -T 8 -f Burton-576_S1_L001_R1_001.fastq -r Burton-
576_S1_L001_R2_001.fastq -o 30 -w ps_overlapped30.fastq -F & 
Step 3: Run the workﬂow pipeline:  
./workflow.sh name 0.97 V4EMB  
3.1 extracting out the barcodes and primers associated with a particular samples.txt ﬁle. 
Output is a tabbed format ﬁle with the ﬁelds: read ID, sample ID primer sequence primer 
barcode q-score  
$BIN/process_miseq_reads.pl $BIN samples.txt reads/overlapped.fastq $primer 8 0 
$name T > $rekeyedtabbedfile 
3.2 Making a fasta ﬁle of all identical sequences (ISU), and an index of those sequences  
 $BIN/group_gt1.pl $rekeyedtabbedfile $name 
3.3 Clustering at 97% identity using usearch (i.e., make OTU), also performs chimera 
ﬁlter singleton reads are excluded  
 $BIN/usearch -cluster_otus data_$name/groups_uclust.fa -otu_radius_pct 3 -otus 
data_$name/clustered_otus_usearch.fa 
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 $BIN/usearch -usearch_global $groups_fa_file -db 
data_$name/clustered_otus_usearch.fa -strand plus -id 0.97 -uc $c95file 
3.4 Regenerating the tabbed reads ﬁle with each read tagged as to its OTU and ISU group 
membership  
 $BIN/map_otu_isu_read_us7.pl $c95file $reads_in_groups_file 
$rekeyedtabbedfile > $mappedfile 
3.5 Making two tables of counts in the analysis directory for OSU and ISU sequences 
gather the seed sequences for each OTU. Transpose the dataset for ease of import into 
QIIME  
 $BIN/get_tag_pair_counts_ps.pl $mappedfile $CUTOFF $name 
 $BIN/get_seed_otus_uc7.pl $c95file $groups_fa_file 
analysis_$name/OTU_tag_mapped.txt > analysis_$name/OTU_seed_seqs.fa 
 Rscript $BIN/OTU_to_QIIME.R analysis_$name 
3.6 Using mothur to annotate the OTU sequences against the Silva database (v119) 
mothur "#classify.seqs(fasta=analysis_$name/OTU_seed_seqs.fa, 
template=$TEMPLATE, taxonomy=$TAXONOMY, cutoff=70, probs=T, processors=4)" 
 $BIN/add_taxonomy_mothur.pl $TAX_FILE 
analysis_$name/td_OTU_tag_mapped.txt > 
analysis_$name/td_OTU_tag_mapped_lineage.txt 
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Appendix C: Recipe of microbiological culture media used in the thesis 
Columbia Blood Agar (CBA)  
The CBA was made with Difco™ CBA Base, contents were showed in g/L 
Pancreatic Digest of Casein  10.0  
Proteose Peptone No.3   5.0 
Yeast Extract     5.0 
Beef Heart, Infusion from 500g 3.0 
Corn Starch    1.0 
Sodium Chloride   5.0 
Agar     15.0 
5% volume of sterile defibrinated sheep blood were added to the base after autoclave 
Columbia CNA Agar, g/L (Final pH 7.3 +/- 0.2 at 25 ℃) 
Pancreatic Digest of Casein  12.0  
Peptic Digest of Animal Tissue 5.0 
Yeast Extract     3.0 
Beef Extract    3.0 
Corn Starch    1.0 
Sodium Chloride   5.0 
Agar     13.5 
Colistin    0.01 
Nalidixic Acid   0.01 
5% volume of sterile defibrinated sheep blood were added to the base after autoclave 
Chocolate Agar ingredients, g/L (Final pH 7.2 +/- 0.2 at 25 ℃) 
Proteose Peptone  20.0 
Sodium Chloride  5.0 
Dipotassium Phosphate 0.50 
Dextros   0.50 
Agar    15.0 
Anaerobic Blood Agar ingredients, g/L 
Casein Peptone 15 
Sodium Chloride 5 
Soy Peptone  5 
Yeast Extract  5 
L-Cystine  0.4 
Vitamin K  0.01 
Hemin   0.005 
Agar   20 
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MacConkey Agar ingredients, g/L 
Peptone  17.0  
Proteose peptone 3.0 
Lactose  10.0 
NaCl   5.0 
Crystal Violet  0.001 
Neutral Red  0.03 
Bile Salts  1.5 
Agar   13.5 
Anaerobic Phenylethyl Alcohol (PEA) Agar, g/L 
Pancreatic and Enzymatic Digests of Casein 15.0 
Papaic Digest of Soybean Meal  5.0g 
Sodium Chloride    5.0g 
Yeast Extract     5.0g 
Phenylethanol     2.5g 
Reducing Agents/Peroxide Inhibitors  1.5g 
Vitamin K     0.01 
Hemin      0.005 
Cystine     0.0004 
Agar      15.0 
5% volume of sterile defibrinated sheep blood were added to the base after autoclave 
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